&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW 
3DJHRI 

&/,1,&$/678'<[ZIP_CODE]&2/

',$&(5(,12,170(17
*/2%$/[ZIP_CODE]&2/180%(5&&3
[ZIP_CODE]&2/$0(1'0(17


3URWRFRO7LWOH
$Q,QWHUQDWLRQDO0XOWLFHQWHU2SHQODEHO/RQJ7HUP([WHQVLRQ 6WXG\(YDOXDWLQJWKH6DIHW\RI
'LDFHUHLQ2LQWPHQW7RSLFDO)RUPXODWLRQLQ6XEMHFWVZLWK(SLGHUPRO\VLV%XOORVD6LPSOH[
(%6
,1'1XPEHU
(XGUD&71XPEHU

,QGLFDWLRQ6WXGLHG
(SLGHUPRO\VLV%XOORVD6LPSOH[
3URWRFRO'DWH
0$<
6SRQVRU$GGUHVV
&DVWOH&UHHN3KDUPDFHXWLFDOV//&
&HQWXU\'ULYH6XLWH3DUVLSSDQ\1-8QLWHG6WDWHVRI$PHULFD




&RQILGHQWLDOLW\6WDWHPHQW
7KLVGRFXPHQWLVFRQILGHQWLDODQGLVDSULYLOHJHGFRUUHVSRQGHQF HRI&DVWOH&UHHN3KDUPDFHXWLFDOV//&
$FFHSWLQJWKLVGRFXPHQWFRQVWLWXWHVDQDJUHHPHQWE\WKHUHFLSLH QWWKDWQRXQSXEOLVKHGLQIRUPDWLRQKHUHLQ
FRQWDLQHGZLOOEHXVHGGLVFORVHGRUSXEOLVKHGZLWKRXW&DVWOH& UHHN3KDUPDFHXWLFDOVÂ¶SULRUZULWWHQ
DSSURYDO
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

,19(67,*$7256321625$*5((0(17
,KDYHUHFHLYHGDQGUHDGWKH,QYHVWLJDWRUÂ¶V%URFKXUHIRUWRSLFD O'LDFHUHLQ2LQWPHQW
&&3,KDYHUHDGWKH&&3 SURWRFRODPHQGPHQWDQGDJUHHWRFRQGXFWWKHVWXG\
DVRXWOLQHGLQWKLVSURWRFRODQGUHOHYDQWUHYLVLRQV,DJUHHWR PDLQWDLQWKHFRQILGHQWLDOLW\RIDOO
LQIRUPDWLRQUHFHLYHGRUGHYHORSH GLQFRQQHFWLRQZLWKWKLVSURWR FRO




3ULQWHG1DPHRI,QYHVWLJDWRU





6LJQDWXUHRI,QYHVWLJDWRU



'DWH

















Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI


6321625Â¶6&217$&7,1)250$7,21


5ROHLQ6WXG\ 1DPH $GGUHVVDQG7HOHSKRQH
1XPEHU
&OLQLFDO2SHUDWLRQV/HDGHU6SRQV RU
&OLQLFDO2SHUDWLRQV/HDGHU6SRQVRU
5HVSRQVLEOH3K\VLFLDQ6SRQVRU
*OREDO&OLQLFDO3URMHFW0DQDJHU 
0HGLFDO0RQLWRU  
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

7$%/(2)&217(176
5(35(6(17$7,9(6)520&$67/(&5((.3+$50$&(87,&$/6&2175$&7
5(6($5&+25*$1,=$7,21  
,19(67,*$7256321625$*5((0(17 
 6<1236,6  
/,672)$%%5(9,$7,216$1''(),1,7,2162)7(506
 6800$5<2)&+$1*(
 ,1752'8&7,21 
'RVHDQG7UHDWPHQW'XU DWLRQ5DWLRQDOH 
5LVNVDQGRU%HQHILWVWR6XEMHFWV
 75,$/2%-(&7,9(6 
2EMHFWLYH 
 (1'32,176 
6DIHW\(QGSRLQWV 
 ,19(67,*$7,21$/3/$1
2YHUDOO6WXG\'HVLJQ 
 6(/(&7,21',6326,7,212)678'<3238/$7,21 
1XPEHURI6XEMHFWV
6WXG\3RSXODWLRQ&KDUDFWHULVWLFV 
,QFOXVLRQ&ULWHULD 
([FOXVLRQ&ULWHULD 
&RQFRPLWDQWWKHUDSLHV  
3URKLELWHGWKHUDSLHV 
,QIHFWHG/HVLRQV 
6XEMHFW'LVFRQWLQXDWLRQIURPWKH6WXG\ 
6XEMHFW,GHQWLILHU6, 
5HSODFHPHQW6XEMHFWV  
 ,19(67,*$7,21$/3/$1
6WXG\)ORZ&KDUW 
6WXG\9LVLWV'HVFULSWLRQDQG3URFHGXUHV
'D\%DVHOLQH9LVLW  
&\FOH6WDUW9LVLW 
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI
0LG&\FOH9LVLW 
(QGRI&\FOH9LVLW 
(%6/HVLRQ,GHQWLILFDWLRQ  
6XEMHFW,QVWUXFWLRQV 
(%6/HVLRQ&DUH  
%OLVWHUODQFLQJNLW 
%DQGDJLQJ'UHVVLQJ8VH 
6WXG\'XUDWLRQ 
6WXG\0HGLFDWLRQV  
6WXG\PHGLFDWLRQLGHQWLW\ 
6WXG\PHGLFDWLRQIRUPXODWLRQ 
6WXG\PHGLFDWLRQSDFNDJLQJDQGODEHOLQJ 
0HWKRGRIWUHDWPHQWDVVLJQPHQW
6XEMHFWWUHDWPHQWDVVLJQPHQW 
'LVSHQVLQJVWXG\PHGLFDWLRQ
6WXG\PHGLFDWLRQDSSOLFDWLRQ 
'RVHFRPSOLDQFHUHFRUG  
'RVHPRGLILFDWLRQ 
6WXG\PHGLFDWLRQ0DQDJHPHQW 
$FFRXQWDELOLW\  
5HWXUQDQGGLVSRVLWLRQRIVWXG\VXSSOLHV 
%OLQGLQJ  
9HULILFDWLRQRIEOLQGLQJ 
 678'<$66(660(176 
6DIHW\(YDOXDWLRQV 
'HPRJUDSKLFV0HGLFDO+LVWRU\ 
9LWDO6LJQV  
&OLQLFDOODERUDWRU\VDPSOLQJ  
(OHFWURFDUGLRJUDP(&*0RQLWRULQJ 
3UHJQDQF\WHVWV 
2WKHU(YDOXDWLRQV 
&OLQLFDO$VVHVVPHQW  
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI
7RWDO9ROXPHRI%ORRG&ROOHFWHG
$'9(56((9(176
$GYHUVHHYHQWVV  
$GYHUVH'UXJ5HDFWLRQ  
8QH[SHFWHG$GYHUVH'UXJ5HDFWLRQ 
$VVHVVPHQWVRI$GYHUVH(YHQWVE\WKH,QYHVWLJDWRU 
$VVHVVPHQWRI6HYHULW\ 
&DXVDOLW\$VVHVVPHQW  
$GYHUVH(YHQWVRI6SHFLDO,QWHUHVW 
6HULRXV$GYHUVHHYHQWV6$( 
6HULRXV$GYHUVH(YHQW$GYHUVH(YHQWVRI6SHFLDO,QWHUHVW5HSRUW LQJÂ±
3URFHGXUHVIRU,QYHVWLJDWRUV  
,QLWLDO5HSRUWV  
)ROORZXS5HSRUWV  
([SHGLWHG5HSRUWV 
35(*1$1&<5(3257,1* 
67$7,67,&$/$1$/<6(6 
$QDO\VLV3RSXODWLRQV 
'DWD$QDO\VLV  
0LVVLQJ'DWD+DQGOLQJ0HWKRGV 
6XEMHFW,QIRUPDWLRQ 
$QDO\VLVRI6DIHW\  
,QWHULP$QDO\VLV 
6DPSOH6L]H&DOFXODWLRQ 
',5(&7$&&(66726285&('$7$'2&80(176
6WXG\0RQLWRULQJ 
(7+,&6 
(WKLFV5HYLHZ 
(WKLFDO&RQGXFWRIWKH6WXG\ 
:ULWWHQ,QIRUPHG&RQVHQW$VVHQW 
'$7$+$1'/,1*$1'5(&25'.((3,1* 
(OHFWURQLF&DVH5HSRUW)RUPV
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI
,QVSHFWLRQRI5HFRUGV 
5HWHQWLRQRI5HFRUGV 
38%/,&$7,2132/,&< 
5()(5(1&(6 
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI
6<1236,6

1DPHRI6SRQVRU&RPSDQ\
&DVWOH&UHHN3KDUPDFHXWLFDOV//&
1DPHRI,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW
1DPHRI$FWLYH,QJUHGLHQW'LDFHUHLQ
7LWOHRI6WXG\$Q,QWHUQDWLRQDO0XOWLFHQWHU2SHQODEHO/RQJ7HUP([WHQVLRQ 6WXG\(YDOXDWLQJWKH6DIHW\
RI'LDFHUHLQ2LQWPHQW7RSLFDO )RUPXODWLRQLQ6XEMHFWVZLWK( SLGHUPRO\VLV%XOORVD
6LPSOH[(%6
6WXG\FHQWHUV $SSUR[LPDWHO\
6WXGLHGSHULRG\HDUV(VWLPDWHGGDWHILUVWVXEMHFWHQUROOHG129
(VWLPDWHGGDWHODVWVXEM HFWFRPSOHWHG1293KDVHRIGHYHORSPHQW

2EMHFWLYH7KHSULPDU\REMHFWLYHRIWKLVVW XG\LVWRHYDOXDWHWKHORQJWHU PVDIHW\DQGWROHUDELOLW\RI
'LDFHUHLQ2LQWPHQWIRUWUHDWPHQWF\FOHVLQVXEMHFWVZLWK( %6WKDWZHUHSUHYLRXVO\
HQUROOHGLQVWXGLHV&&3RU&&3
0HWKRGRORJ\7KLVLVDQLQWHUQDWLRQDOPXOWL FHQWHURSHQODEHOORQJWHUPH[ WHQVLRQVWXG\HYDOXDWLQJWKH
VDIHW\RIWRSLFDO'LDFHUHLQ2L QWPHQWIRUWKHWUHDWPHQWRIVX EMHFWVZLWK(%6$W9LVLW
(%6VXEMHFWVZKRSDUWLFLSDWHLQ WKH&&3GRXEOHEOLQGVD IHW\DQGHIILFDF\VWXG\
RUSDUWLFLSDWHLQWKH&&3 3.VWXG\IHHGHUVWXGLHVZKR PHHWDOOWKH
LQFOXVLRQH[FOXVLRQFULWHULDZLOOEHHOLJLEOHWRFRPSOHWHWZRW UHDWPHQWF\FOHVRI&&3

(DFKWUHDWPHQWF\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWRQFHGDLO\DWKRPHVWXG\
PHGLFDWLRQDSSOLFDWLRQVIROORZH GE\ZHHNVRIIWUHDWPHQWRQO \LQYHVWLJDWRUDSSURYHG
EODQGQRQPHGLFDWHGHPROOLHQWPRLVWXUL]HUURXWLQHFOHDQVLQJS URGXFWVDQGVXQVFUHHQVZLWK
DPD[LPXPRIWZRWUHDWPHQWF\FOH VDOORZHGIRUXSWRZHHNV

$W%DVHOLQHFRUUHVSRQGLQJWRWKH ILQDOVWXG\YLVLWRIWKHIHHG HUVWXG\WKHLQYHVWLJDWRUZLOO
SHUIRUPDFOLQLFDODVVHVVPHQWDQGGHWHUPLQHLIDQ\RIWKHVXEMH FWÂ¶VOHVLRQVUHTXLUHWUHDWPHQW
XSWR%6$,IWKHVXEMHFWKDVDFWLYHOHVLRQVDVGHWHUPLQH GE\WKH,QYHVWLJDWRUÂ¶VFOLQLFDO
DVVHVVPHQWWKHVXEMHFWZLOOLQLWLDWHDF\FOHRIRQFHGDLO\DW KRPHVWXG\PHGLFDWLRQ
DSSOLFDWLRQWRWKHLU(%6OHVLRQV IRUZHHNVWUHDWPHQWSHULRG IROORZHGE\DQZHHNSHULRG
ZKHUHQRWUHDWPHQWZLOOEHDGPLQLVWHUHG6XEMHFWVSUHVHQWLQJZL WKQRDFWLYHOHVLRQVDV
GHWHUPLQHGE\WKH,QYHVWLJDWRUÂ¶VFOLQLFDODVVHVVPHQWZLOOQRW EHJLQWUHDWPHQWDQGLQVWHDG
ZLOOEHLQVWUXFWHGWRUHWXUQWRWKHFOLQLFIRUUHHYDOXDWLRQLQ ZHHNVRUXSRQZRUVHQLQJRI
(%6OHVLRQVZKLFKHYHUKDSSHQVILUVW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI


'XULQJWKHWUHDWPHQWSHULRGRIHDFKF\FOHVXEMHFWVFDUHJLYHUV ZLOODSSO\DWKLQOD\HURIWKH
DVVLJQHGVWXG\PHGLFDWLRQVXIILFLHQWWRFRYHUWKHVXEMHFWÂ¶V(% 6OHVLRQVDQGDSSUR[LPDWHO\Ã´
LQFKFPRIVXUURXQGLQJXQLQYROYHGVNLQDQGJHQWO\UXELQW KHVWXG\PHGLFDWLRQ
6XEMHFWVFDUHJLYHUVZLOODSSO\WKHDVVLJQHGVWXG\PHGLFDWLRQWR DOO(%6OHVLRQVLQFOXGLQJ
DQ\QHZ(%6OHVLRQVWKDWGHYHORSXSWR%6$RQFHGDLO\H YHU\HYHQLQJXQWLOWKH
OHVLRQVUHVROYHIRUZHHNV$IWHUZHHNVWKHVXEMHFWZLOOU HWXUQWRWKHVLWHWRUHWXUQWKH
VWXG\PHGLFDWLRQDQGUHPDLQRIIVWXG\PHGLFDWLRQIRUZHHNV7 KHLQYHVWLJDWRUZLOOUH
HYDOXDWHWKHVXEMHFWDIWHUWKH ZHHNVRIIWKHUDS\DQGLIDQ\R IWKHVXEMHFWÂ¶VOHVLRQVUHTXLUH
WUHDWPHQWXSWR%6$WKHVXEMHFWZLOOEHJLQDQRWKHUWUHDWP HQWF\FOHIRUDPD[LPXPRI
WZRWUHDWPHQWF\FOHVDOORZHGIRUXSWRZHHNV

6DIHW\ZLOOEHPRQLWRUHGWKURXJKRXW WKHVWXG\E\UHSHDWHGFOLQL FDODQGODERUDWRU\
HYDOXDWLRQVYLWDOVLJQV(&*PRQLWRULQJDQGDGYHUVHHYHQWPRQLWRULQJ

7KHGXUDWLRQRIDVXEMHFWÂ¶VSDU WLFLSDWLRQLQWKHH[WHQVLRQVWXG \PD\EHDVVKRUWDVZHHNV
RUDVORQJDVZHHNVGHSHQGLQJRQWKHF\FOHLQLWLDWLRQVFKHGX OH6XEMHFWVPD\QRWVWDUWD
QHZWUHDWPHQWF\FOHSDVW:HHN IURP%DVHOLQH9LVLWZLWKRXWSU LRUVSRQVRUDSSURYDO
1XPEHURIVXEMHFWVSODQQHG
$SSUR[LPDWHO\VXEMHFWVDUHH[S HFWHGWREHHQUROOHGLQWKLVV WXG\DWDSSUR[LPDWHO\
LQWHUQDWLRQDOLQYHVWLJDWLRQDOFHQWHUV7KHDFWXDOQXPEHURIVXEMHFWVWKDWDUHHQUROOHGZLOOGHSHQGRQWKHILQDOQXPEHURI(%6 VXEMHFWVZKRSDUWLFLSDWHLQW KH&&3RU
SDUWLFLSDWHLQWKH&&3VWXG \
'LDJQRVLVDQGPDLQFULWHULDIRULQFOXVLRQH[FOXVLRQ
,QFOXVLRQFULWHULD 
6XEMHFWKDVDGRFXPHQWHGJHQHWLF PXWDWLRQFRQVLVWHQWZLWK(%6
6XEMHFWVZKRSDUWLFLSDWHGLQWKH&&3RUW KH&&3VWXG\DUHHOLJLEOH
WREHUROOHGLQWRWKH&&3RSHQODEHOH[WHQVLRQVWXG\U HJDUGOHVVRIWKHLU
FRPSOHWLRQVWDWXVRQWKHIHHGHUVWXG\
6XEMHFWFDUHJLYHUDJUHHVWRUHSRUWXVHRIDQ\WRSLFDOWKHUDSLHV DSSOLHGWR(%6OHVLRQV
HJPHGLFDWHGFOHDQVHUVEOHDFKEDWKVWRSLFDODQWLVHSWLFVW RSLFDOGLVLQIHFWDQWV
WRSLFDOVWHURLGVHWF
,IWKHVXEMHFWLVDZRPDQRIFK LOGEHDULQJSRWHQWLDOVKHKDVD QHJDWLYHXULQH
SUHJQDQF\WHVWDQGDJUHHVWRXVHDQDSSURYHGHIIHFWLYHPHWKRGRIELUWKFRQWURODV
GHILQHGE\WKLVSURWRFROVHH6 HFWLRQIRUWKHGXUDWLRQRI WKHVWXG\
6XEMHFWLVQRQODFWDWLQJDQGLVQRWSODQQLQJIRUSUHJQDQF\GXULQJWKHVWXG\SHULRG
6XEMHFWLVZLOOLQJDQGDEOHWRIROORZDOOVWXG\LQVWUXFWLRQVDQ GWRDWWHQGDOOVWXG\YLVLWV
6XEMHFWFDUHJLYHULVDEOHWRFRPSUHKHQGDQGZLOOLQJWRVLJQDQ ,QIRUPHG&RQVHQW
DQGRU$VVHQW)RUP
([FOXVLRQFULWHULD
6XEMHFWKDV(%6OHVLRQVWR EHWUHDWHGWKDWDUHLQIHFWHG LH(%6OHVLRQVWKDWUHTXLUH
WKHUDS\WRWUHDWDQLQIHFWLRQ
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

6XEMHFWKDVHYLGHQFHRIDV\VWHPL FLQIHFWLRQRUKDVXVHGV\VWHP LFDQWLELRWLFVZLWKLQ
GD\VSULRUWR%DVHOLQH
7KHVXEMHFWZDVGLVFRQWLQXHGIURP WKHIHHGHUVWXG\GXHWRDQDG YHUVHHYHQW
6XEMHFWKDVH[SHULHQFHGDFKDQJHLQFOLQLFDOVWDWXVIURPWKHIH HGHUVWXG\WKDWLQWKH
LQYHVWLJDWRUÂ¶VRSLQLRQSXWVWKHVXEMHFWDWXQGXHULVNWRSDUWL FLSDWH
,QYHVWLJDWLRQDOSUR GXFWGRVDJHDQGPRGHRIDGPLQLVWUDWLRQ
'LDFHUHLQ2LQWPHQWDGPLQLVWHUHGWRSLFDOO\RQFHGDLO\
'XUDWLRQRIVWXG\DQGWUHDWPHQW
$SSUR[LPDWHO\ZHHNV
5HIHUHQFHWKHUDS\GRVDJHDQGPRGHRIDGPLQLVWUDWLRQ
1RWDSSOLFDEOH(YHU\VXEMHFWRQWKLVVWXG\ZLOOEHDVVLJQHGWR 'LDFHUHLQ2LQWPHQW
6DIHW\HYDOXDWLRQV$VVHVVPHQWRIDGYHUVHHYHQWV(&*VYLWDOVLJQVFOLQLFDODVVHV VPHQWDQGODERUDWRU\WHVWVZLOO
EHSHUIRUPHGWKURXJKRXWWKHVWXG\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

/,672)$%%5(9,$7,216$1''(),1,7,2162)7(506

$EEUHYLDWLRQ 7HUP
$( $GYHUVH(YHQW
$/7 $ODQLQH$PLQRWUDQVIHUDVH
$1&29$ $QDO\VLVRI&RYDULDQFH
$67 $VSDUWDWH$PLQRWUDQVIHUDVH
%6$ %RG\6XUIDFH$UHD
Âƒ& 'HJUHHV&HQWLJUDGH
&0+ &RFKUDQ0DQWHO+DHQV]HO
&5 &OLQLFDOO\5HOHYDQW
&5$ &OLQLFDO5HVHDUFK$VVRFLDWH
&5) &DVH5HSRUW)RUP
&52 &RQWUDFW5HVHDUFK2UJDQL]DWLRQ
(%6 (SLGHUPRO\VLV%XOORVD6LPSOH[
HJ )RU([DPSOH/DWLQH[HPSODJUDWLD
(& (WKLFV&RPPLWWHH
&5) &DVH5HSRUW)RUP
('& (OHFWURQLF'DWD&DSWXUH
'(% '\VWURSKLF(SLGHUPRO\VLV%XOORVD
Âƒ) 'HJUHHV)DKUHQKHLW
)'$ )RRGDQG'UXJ$GPLQLVWUDWLRQ
** UDP
*&3 *RRG&OLQLFDO3UDFWLFH
+&* +XPDQ&KRULRQLF*RQDGRWURSKLQ
+,3$$ +HDOWK,QVXUDQFH3RUWDELOLW\DQG$FFRXQWDELOLW\$FWRI 
+J 0HUFXU\
,% ,QYHVWLJDWRUÂ¶V%URFKXUH
,&) ,QIRUPHG&RQVHQW)RUP
,&+ ,QWHUQDWLRQDO&RQIHUHQFHRQ+DUPRQL]DWLRQ
LH 7KDW,V/DWLQLGHVW
,*$ ,QYHVWLJDWRUÂ¶V*OREDO$VVHVVPHQW
,5% ,QVWLWXWLRQDO5HYLHZ%RDUG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

$EEUHYLDWLRQ
7HUP
,57 ,QWHUDFWLYH5HVSRQVH7HFKQRORJ\
,77 ,QWHQW7R7UHDW
/2&) /DVW2EVHUYDWLRQ&DUULHG)RUZDUG
/6$ /HVLRQ6XUIDFH$UHD
0HG'5$ 0HGLFDO'LFWLRQDU\IRU5HJXODWRU\$FWLYLWLHV
0O 0LOOLOLWHU
0P 0LOOLPHWHU
Â—0RO 0LFURPRODU
1&5 1RW&OLQLFDOO\5HOHYDQW
156 1XPHULF5DWLQJ6FDOH
27& 2YHU7KH&RXQWHU
351 $VQHHGHG
33 3HU3URWRFRO
6$( 6HULRXV$GYHUVH(YHQW
6, 6XEMHFW,GHQWLILHU
623 6WDQGDUG2SH UDWLRQ3URFHGXUH
86 8QLWHG6WDWHV
:2&%3 :RPHQRIFKLOGEHDULQJSRWHQWLDO
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

6800$5<2)&+$1*(

6HFWLRQ 'HVFULSWLRQ
RI&KDQJH5DWLRQDOH
6LJQDWXUH
SDJH&RQWHQWPRGLILHG1HZWLWOHDQGUHSUHVHQWDWLYH
6SRQVRUÂ¶V
FRQWDFWLQIRUPDWLRQ&RQWHQW$GGHG 6SRQVRU Â¶VFRQWDFWLQIRUPDWLRQSDJHDGGHGWRLQFOXGHQHZ
6SRQVRU3K\VLFLDQDQGWHDPPHPEHUV8SGDWHGWRLQFOXGHQHZ&520HGLFDO0RQLWRU
6\QRSVLV &RQWHQW
PRGLILHG8SGDWLQJSDUWLFLSDWLRQWRDOORZDOOVXEMHFWVLQWRWKHVWXG\
6\QRSVLV &RQWHQW
PRGLILHG,QFOXVLRQ&ULWHULD&ODULILFDWLRQUHJDUGLQJDOORZLQJQRW
RQO\IHHGHUVWXG\FRPSOHWHUVLQ WRWKHVWXG\EXWDOORZLQJDOO
VXEMHFWVZKRSDUWLFLSDWHGWRHQUROO
 &RQWHQW
PRGLILHG8SGDWLQJSDUWLFLSDWLRQWRDOORZDOOVXEMHFWVLQWRWKHVWXG\
 &RQWHQW
PRGLILHG8SGDWLQJSDUWLFLSDWLRQWRDOORZDOOVXEMHFWVLQWRWKHVWXG\
 &RQWHQW
PRGLILHG&ODULILFDWLRQUHJDUGLQJDOORZLQJDOO(%6VXEMHFWVRQDQG
WRHQWHUWKHH[WHQVLRQVWXG\
 &RQWHQW
PRGLILHG,QFOXVLRQ&ULWHULD&ODULILFDWLRQUHJDUGLQJDOORZLQJQRWRQO\IHHGHUVWXG\FRPSOHWHUVLQ WRWKHVWXG\EXWDOORZLQJDOO
VXEMHFWVZKRSDUWLFLSDWHGWRHQUROO
 &RQWHQW
PRGLILHG&ODULILFDWLRQUHJDUGLQJSDUWLFLSDWLRQRQWKHVWXG\
 &RQWHQW
PRGLILHG8SGDWLQJSDUWLFLSDWLRQWRDOORZDOOVXEMHFWVLQWRWKHVWXG\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

,1752'8&7,21
(SLGHUPRO\VLVEXOORVDVLPSOH[(%6LVDUDUHJHQHWLFVNLQGLV HDVHFKDUDFWHUL]HGE\IUDJLOLW\RI
WKHVNLQDQGPXFRXVPHPEUDQHVUHVXOWLQJLQSDLQIXOEOLVWHUVDQG HURVLRQVDIWHUPLQRUWUDXPD
DQGLVDVVRFLDWHGZLWKVLJQLILFDQWPRUELGLW\DQGPRUWDOLW\ (%6LVERWKDSHGLDWULFDQGDQDGXOW
GLVHDVHWKDWWHQGVWRDIIHFW\RXQJHUSDWLHQWVPRVWVHYHUHO\0R VWSDWLHQWVZLWK(%6KDYHWR
RIERG\VXUIDFHDUHD%6$DIIHFWHGE\EOLVWHUVDOWKRXJKWKHUHFDQEHZLGHYDULDWLRQV(%6
IUHTXHQWO\KDVSDOPDUDQGSODQWD ULQYROYHPHQWZKLFKFDQVLJQLI LFDQWO\DIIHFWSDWLHQWVÂ¶PRELOLW\
DQGTXDOLW\RIOLIH,QDGGLWLRQ WREOLVWHULQJDQGVNLQLQIHFWL RQVSDWLHQWVVXIIHUIURPSDLQDQG
VHYHUHFRQWLQXRXVLWFKLQJ7KHUH DUHFXUUHQWO\QRDSSURYHGWUH DWPHQWVIRU(%6
7KHVLPSOH[IRUPLVRIPDMRU W\SHVRI(%DQGLVFODVVLILHG E\VNLQEOLVWHUGHYHORSPHQWLQWKH
EDVDOHSLGHUPLV7KRVHERUQZLWK(%DUHRIWHQFDOOHGÂ³%XWWHUIO\&KLOGUHQÂ´EHFDXVHDVWKH
DQDORJ\JRHVWKHLUVNLQLVDVIUD JLOHDVWKHZLQJVRIDEXWWHU IO\7KHSUHYDOHQFHRILQKHULWHG(%
LQWKH86LVHVWLPDWHGWREHDSSUR[LPDWHO\SHUPLOOLRQOLYH ELUWKVDFFRUGLQJWRWKH1DWLRQDO
(SLGHUPRO\VLV%XOORVD5HJLVWU\ LQWKH86WKHUHDUHDURXQGQ HZ(%FDVHVSHUPLOOLRQOLYH
ELUWKVRIZKLFKDSSUR[LPDWHO\DUH(%6 
'LDFHUHLQ2LQWPHQWLVDWRSLFDORLQWPHQWFRQWDLQLQJGLDFHUHL QELV>DFHW\OR[\@
GLK\GURGLR[RDQWKUDFHQHFDUER[\OLFDFLGDOVRNQRZQDV GLDFHW\O[LOCATION_006]HLQDKLJKO\
SXULILHGDQWKUDTXLQRQHGHULYDWLY HDQGLVEHLQJGHYHORSHGIRUW KHWUHDWPHQWRI(%67KHFDSVXOH
IRUPXODWLRQRIGLDFHUHLQLQWHQGH GIRURUDOXVHDQGV\VWHPLFDE VRUSWLRQZDVLQLWLDOO\DSSURYHG
IRUXVHLQRVWHRDUWKULWLV2$LQ)UDQFHLQDV$UWRGDUÂŠ$57ÂŠRU=RQGDUÂŠ6LQFHWKHQ
LWKDVUHFHLYHGPDUNHWLQJDXWKRU L]DWLRQLQRYHUFRXQWULHVLQ (XURSH6RXWK$PHULFDDQG$VLD
,WLVFODVVLILHGDVD6\PSWRPDWLF6ORZ$FWLQJ'UXJLQ2$)ROOR ZLQJRUDODGPLQLVWUDWLRQRIWKH
FDSVXOHIRUPXODWLRQGLDFHUHLQLVUDSLGO\PHWDEROL]HGWRWKHGHDFHW\ODWHGDFWLYHPHWDEROLWH[LOCATION_006]HLQ6LPLODUO\GLDFHUHLQLQWKHWRSLFDOIRUPXODWLRQLVK\GURO\]HGW R[LOCATION_006]HLQLQWKHHSLGHUPLVDQGGHUPLV
IROORZLQJDGPLQLVWUDWLRQ'LDFHUHLQDQG[LOCATION_006]HLQKDYHEHHQVKRZQW RLQKLELWWKHLQYLWURDQGLQYLYR
SURGXFWLRQDQGDFWLYLW\RILQWHUOH XNLQÈ•,/È•DQGRWKHUSURLQIOD[COMPANY_003]WRU\F\WRNLQHV,WKDVD
QRYHOPRGHRIDFWLRQWKDWGLIIHUHQWLDWHVLWIURPQRQVWHURLGDO DQWLLQIOD[COMPANY_003]WRU\GUXJV16$,'V
DQGRWKHUFRQYHQWLRQDOIRUPVRIGUXJWKHUDS\
,/È•LVDSURLQIOD[COMPANY_003]WRU\F\WRNL QHWKDWKDVEHHQOLQNHGWRD QXPEHURILQIOD[COMPANY_003]WRU\DQG
DXWRLPPXQHGLVHDVHVLQFOXGLQJU KHXPDWRLGDUWKULWLV5$2$K HPRSKLOLFDUWKURSDWK\JRXW\
DUWKULWLVW\SHGLDEHWHVPHOOLWXV7'0GLDEHWLFQHSKURSDWK \'1DQG(%6 ,QYLWURDQG LQ
YLYRDQLPDOVWXGLHVKDYHVKRZQWKDWERWKGLDFHUHLQDQGLWVDFWLYHPH WDEROLWH[LOCATION_006]HLQLQKLELWWKH
SURGXFWLRQDQGDFWLYLW\RISURL QIOD[COMPANY_003]WRU\DQGSURFDWDEROLFF\WRNLQHVVXFKDV,/DQG,/
DQGWKHH[SUHVVLRQRILQGXFLEOHQLWULFR[LGHV\QWKDVHL126DQGWXPRUQHFURVLVIDFWRUÄ®71)
Ä®
3ULRUWRWKHILUVWDSSOLFDWLRQRIGLDFHUHLQLQDSKDVH(%6WU HDWPHQWVWXG\DVLQJOHWRSLFDO
DSSOLFDWLRQRIPJ'LDFHUHLQ &UHDPZDVDSSOLHGWRWKHVNLQRIDSDWLHQWZLWK(%6 
7KH
DPRXQWRI[LOCATION_006]HLQGHWHFWHGLQWKH SDWLHQWÂ¶VXULQHZDVRIWKH DPRXQWGHWHFWHGLQWKHXULQHDIWHU
RUDODGPLQLVWUDWLRQRIWKHVDP HGRVH3KDUPDFRNLQHWLF3.DQDO\VLVRI[LOCATION_006]HLQZDVSHUIRUPHGLQ
SDWLHQWVZLWK(%6IURPWKHSKDVHWULDOGHVFULEHGEHORZ6HUXP DQGXULQHVDPSOHVZHUH
FROOHFWHGLPPHGLDWHO\IROORZLQJ ZHHNVRIDGPLQLVWUDWLRQRI'L DFHUHLQ&UHDPWRRI
WKHVHSDWLHQWV%6$7KHKLJKHVWOHYHORI[LOCATION_006]HLQLQXULQHZDVQJPODQGWKHKLJKHVWOHYHORI
[LOCATION_006]HLQLQVHUXPZDVQJPO7 KLVVHUXPOHYHOUHSUHVHQWVOHVV WKDQRIWKHVHUXPOHYHO
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

GHWHFWDEOHDIWHURUDODGPLQLVWUD WLRQRIDVLQJOHGRVHRIPJ GLDFHUHLQ7KHVHGDWDVXJJHVWWKDW
XSRQWRSLFDODGPLQLVWUDWLRQGLDFHUHLQUHDFKHVFLUFXODWLRQLQWKHIRUPRI[LOCATION_006]HLQD QGLVH[FUHWHGDV
[LOCATION_006]HLQ$GGLWLRQDOO\WKHPRVWFRPPRQO\UHSRUWHGDGYHUVHHIIHFWV DIWHURUDODGPLQLVWUDWLRQVXFK
DVGLDU[LOCATION_006]HDQDXVHDDQGYRPLWLQJRFFXUDWRQO\KLJKHUV\VWHPL FFRQFHQWUDWLRQVZKLFKVKRXOG
QRWEHDFKLHYHGIROORZLQJWRSLFDODGPLQLVWUDWLRQ
3KDVHDQGSKDVHVWXGLHVRI'LDFHUHLQ&UHDPIRUWUHDWPHQW RI(%6KDYHEHHQVXFFHVVIXOO\
FRPSOHWHG%RWKVWXGLHVZHUH FRQGXFWHGLQ(XURSHXQGHU'U-RKD QQ%DXHUDVSULQFLSDO
LQYHVWLJDWRU
$SKDVHFOLQLFDOSLORWVWXG\RIWRSLFDO'LDFHUHLQ&UHDPWR UHGXFHEOLVWHULQJLQSDWLHQWVZLWK
(%6'0JHQHUDOL]HGVHYHUHW\SH ZDVFRPSOHWHGLQDQGLWVUHVXOWVZHUHSXEOLVKHGLQ
)LYHSDWLHQWVZLWK(%6'0LQLWLD OO\DSSOLHG'LDFHUHLQ&UHDP XQGHUQHDWKERWK
DUPSLWVLQWKHILUVWZHHNRSHQODEHOSKDVH7KHQHDFKSDUWLF LSDQWUHFHLYHG'LDFHUHLQ
&UHDPIRURQHDUPSLWDQGSODFHERIRUWKHRWKHULQDVHFRQGUDQ GRPL]HGSODFHERFRQWUROOHG
ZHHNSKDVH7LPHWRORVVRIHIIL FDF\GHILQHGDVKDOYLQJRIW KHHIIHFWREVHUYHGLQSKDVHZDV
FKRVHQDVWKHSULPDU\HQGSRLQW5HVXOWVVKRZHGDVWDWLVWLFDOO\ VLJQLILFDQWUHGXFWLRQRIEOLVWHUV
ZLWKLQWKHILUVWZHHNVRIWKHRS HQODEHOSKDVH,QSKDVH WKHUHZDVQRORVVRIHIILFDF\LQ
ERWKWKHWUHDWHGDQGSODFHERJURXSV
$SKDVHFOLQLFDOVWXG\ZDVF RPSOHWHGLQ7KLVZDVDSODF HERFRQWUROOHGUDQGRPL]HGDQG
GRXEOHEOLQGHGFURVVRYHUVWXG\RIUDQGRPL]HGDQGWUHDWHGSDW LHQWVDJHVWRGLDJQRVHG
ZLWKJHQHUDOL]HGVHYHUH(%6 $ZHHNWUHDWPHQWSHULRGDQGDWKUHHPRQWKIROORZXSSHULRG
ZDVSHUIRUPHGLQERWK<HDUDQG <HDURIWKHVWXG\ZLWKDFU RVVRYHURIJURXSVSODFHERDQG
GLDFHUHLQEHWZHHQ\HDUV'XULQJWKHZHHNWUHDWPHQWSHULRGS DWLHQWVRUWKHLUFDUHJLYHUV
DSSOLHGILQJHUWLSXQLWVRI'L DFHUHLQ&UHDPRUSODFHERRQWRDSUHGHILQHGVNLQDUHD7KUHH
SHUFHQWRIWKHWRWDO%6$ZDVFKRVHQWRJHWKHUZLWKWKHSDWLHQWV ZLWKWKHSUHUHTXLVLWHWKDW
VLJQLILFDQWQXPEHUVRIEOLVWHUVZHUHSUHVHQWDW7LPH
7KHUHVXOWVRIWKHVHVWXGLHVVXJJH VWWKDWWRSLFDOGLDFHUHLQKDV WKHSRWHQWLDOWRGRZQUHJXODWHWKH
DFWLYLW\RI,/È•DQGUHGXFHWKHLQIOD[COMPANY_003]WRU\HIIHFWVLQWKHVN LQRISDWLHQWVZLWK(%67KH
IDYRUDEOHSURGXFWSURILOHRIGLDFH UHLQDQDQWL,/È•VPDOOPROHFXOHSURYLGHVDUDWLRQDOHIRU
LQYHVWLJDWLQJWKHFOLQLFDOXWLOLW\LQUHGXFLQJWKHIUHTXHQF\RU SUHYHQWLQJRIEOLVWHUIRUPDWLRQLQ
SDWLHQWVZLWK(%6
'HWDLOHGLQIRUPDWLRQDERXWWKHSKDVHDQGSKDVHVWXG\GHVLJQ VDQGUHVXOWVDUHSUHVHQWHGLQWKH
'LDFHUHLQ7RSLFDO2LQWPHQW,QYHVWLJDWRUÂ¶V%URFKXUH
7KLVVWXG\LVDQRSHQODEHOORQJ WHUPH[WHQVLRQRIVWXGLHV&&3DUDQGRPL]HG
GRXEOHEOLQGSKDVH,,VWXG\HYDOXDWLQJWKHHIILFDF\DQGVDIHW \RI'LDFHUHLQ2LQWPHQWLQ
VXEMHFWVZLWK(%6DQG&&3D SKDVH,VWXG\HYDOXDWLQJW KHSKDUPDFRNLQHWLFVRI
'LDFHUHLQ2LQWPHQWLQVXEMHFWVZLWK(%6DQGKHDOWK\YROXQWHHUV6XEMHFWVZKRSDUWLFLSDWH
LQWKH&&3RUW KH&&3VWXG\DUHHOLJLEOHWREHUROOHGLQWRWKH&&3
RSHQODEHOH[WHQVLRQVWXG\UHJDUGOHVVRIWKHLUFRPSOHWLRQVWDWXVRQWKHIHHGHUVWXG\

'RVHDQG7UHDWPHQW'XUDWLRQ5DWLRQDOH
,QDGGLWLRQWRWKHORQJKLVWRU\RIFOLQLFDOH[SHULHQFHZLWKGLD FHUHLQDIWHURUDODGPLQLVWUDWLRQ
VWXGLHVZLWKWRSLFDOGLDFHUHLQKDYHEHHQFRQGXFWHG5HVXOWVIUR PDZHHNSKDVHSLORW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI
VWXG\LQ(%6'0SDWLHQWVGHPRQVWUDWHGDVXEVWDQWLDOUHGXFWLRQ LQEOLVWHUVDIWHUZHHNVRI
GDLO\DSSOLFDWLRQRIGLDFHUHLQFUHDP,QWKLVVWXG\WUHDWPH QWFRQWLQXHGRSHQODEHOIRUDQ
DGGLWLRQDOZHHNV,QSHULRG RIWKHVWXG\WKHHIIHFWVODVWH GDQDGGLWLRQDOZHHNVLQSDWLHQWV
DGPLQLVWHUHGGLDFHUHLQRUSODFHERLQGLFDWLQJDGXUDEOHUHVSRQVH IURPWKHLQLWLDORSHQODEHO
ZHHNWUHDWPHQWSHULRG7KHUHZHUHQRDGYHUVHHYHQWVUHSRUWHGGX ULQJWKHVWXG\
$PXOWLFHQWHU(XURSHDQSKDVH SODFHERFRQWUROOHGUDQGRPL]HG GRXEOHEOLQGFURVVRYHU
VWXG\RI(%6SDWLHQWVDJHGWRZDVFRPSOHWHG7KHVWXG \ZDVUXQRYHU\HDUVZLWKD
ZHHNWUHDWPHQWSHULRGDQGPRQWKIROORZXSSHULRGLQHDFK\H DURIWKHVWXG\GLDFHUHLQ
FUHDPRUSODFHER,QWKLVVWXG \WKHGRVHGRVHGXUDWLRQ ZHHNVDQGDSSOLFDWLRQDUHD
%6$HVWDEOLVKHGDKLJKO\VLJQLILFDQWUHGXFWLRQLQEOLVWHU FRXQWVLQERWK\HDUVRIWUHDWPHQW
DWWKHHQGRIWKHZHHNWUHDWPH QWSHULRGDVZHOODVFRQWLQXHGUHVSRQVHDWPRQWKVSRVW
WUHDWPHQWFRPSDUHGWRSODFHER6 HFRQGDU\HQGSRLQWVDOVRGHPRQVW UDWHGDQHIIHFWRIWKH
WUHDWPHQWDUPFRPSDUHGWRSODFHERDVPHDVXUHGE\WLPHWRUHDFK LQLWLDOEOLVWHUFRXQWVDQG
SDWLHQWUHSRUWHGRXWFRPHVRILPSURYHPHQWVLQSDLQDQGLWFKLQJ 7KHUHZHUHQRGUXJUHODWHG
$(VLQWKHVWXG\DQGQRGLVFRQWLQXDWLRQVUHODWHGWRWUHDWPHQW
7KHVHSUHOLPLQDU\FOLQLFDOVWXGL HVGHPRQVWUDWHGSURRIRIFRQFHS WHIILFDF\RIDGLDFHUHLQ
FUHDPLQ(%6'0SDWLHQWV7KLVFXUUHQWWULDOZLOOVHHNWRHVWDE OLVKORQJWHUPVDIHW\DQG
WROHUDELOLW\RIDGLDFHUHLQRLQWPHQWLQSDWLHQWVZLWK(%66XEMHFWVHQWHULQJWKHRSHQODEHO ORQJWHUPH[WHQVLRQVWXG\DIWH UFRPSOHWLQJWKH&&3
RU&&3VWXGLHVZLOOKDYHE HHQH[SRVHGWRWUHDWPHQWZLWK GLDFHUHLQRLQWPHQWRU
SODFHER
5LVNVDQGRU%HQHILWVWR6XEMHFWV
7KHGRVHRIVWXG\PHGLFDWLRQDGPLQLVWHUHGLQWKLVVWXG\LVDQWL FLSDWHGWRLQGXFHWKHUDSHXWLF
EHQHILWZLWKSURORQJHGWUHDWPHQW,WLVDQWLFLSDWHGWKDWFRQWLQ XHGXVHRIWKHVWXG\PHGLFDWLRQ
ZHHNVRQZHHNVRIIZLOOUHGXFHWKHEOLVWHUVHYHULW\RIWKH DIIHFWHGDUHD$GGLWLRQDOO\VXEMHFWV
ZLOOUHFHLYHVWXG\PHGLFDWLRQDW QRFRVWIRUWKHGXUDWLRQRIWK HVWXG\
7KHVDIHW\PRQLWRULQJSUDFWLFHVH PSOR\HGE\WKLVSURWRFROLHYLWDOVLJQVFOLQLFDODQG
ODERUDWRU\HYDOXDWLRQV(&*VD QG$(TXHVWLRQLQJDUHDGHTXDWHWRSURWHFWWKHVXEMHFWVÂ¶VDIHW\
DQGDUHH[SHFWHGWREHVXIILFLHQ WWRGHWHFWDOOWUHDWPHQWHPHUJ HQWDGYHUVHHYHQWV7($(V
7KHDSSUR[LPDWHYROXPHRIEORRG SODQQHGIRUFROOHFWLRQIURPHDF KVXEMHFWRYHUWKHFRXUVHRIWKH
VWXG\LVQRWFRQVLGHUHGWRSUHV HQWXQGXHULVNWRWKHVXEMHFWV 1RIXUWKHUULVNLVSUHVHQWLI
DGGLWLRQDOEORRGLVUHTXLUHGIRU UHFKHFNRIVDIHW\ODERUDWRU\W HVWVDVGHHPHGQHFHVVDU\E\WKH3,
$QLQGLUHFWKHDOWKEHQHILWWRWKH(%6VXEMHFWVHQUROOHGLQWKLV WULDOLVWKHPHGLFDOWHVWLQJUHFHLYHG
DWVFUHHQLQJDQGGXULQJWKHVWXG\DVRXWOLQHGLQWKLVSURWRFRO ZLOOEHSURYLGHGDWQRFRVWWRWKH
VXEMHFW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

75,$/2%-(&7,9(6
2EMHFWLYH
7KHSULPDU\REMHFWLYHRIWKLVVWXG\LVWRHYDOXDWHWKHORQJWHU PVDIHW\DQGWROHUDELOLW\RI
'LDFHUHLQ2LQWPHQWLQVXEMHFWVZLWK(%6WKDWZHUHSUHYLRXVO\ HQUROOHGLQVWXGLHV&&3
RU&&3
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

(1'32,176
6DIHW\(QGSRLQWV
6DIHW\ZLOOEHHYDOXDWHGLQWHUPVRIWKHRFFXUUHQFHRI$(VDQG FKDQJHVLQFOLQLFDOODERUDWRU\
SDUDPHWHUVFOLQLFDOH[DPLQDWLRQILQGLQJVYLWDOVLJQVZHLJKW DQGXULQHPHDVXUHPHQWV
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

,19(67,*$7,21$/3/$1
2YHUDOO6WXG\'HVLJQ
7KLVLVDQLQWHUQDWLRQDOPXOWL FHQWHURSHQODEHOORQJWHUPH[ WHQVLRQVWXG\HYDOXDWLQJWKHVDIHW\
RIWRSLFDO'LDFHUHLQ2LQWPHQWIRUWKHWUHDWPHQWRIVXEMHFWV ZLWK(%6$W%DVHOLQH(%6
VXEMHFWVZKRSDUWLFLSDWHGWKH&&3 GRXEOHEOLQGVDIHW\ DQGHIILFDF\VWXG\RU
SDUWLFLSDWHGLQWKH&&33 .VWXG\IHHGHUVWXGLHVDQG ZKRPHHWDOOWKH
LQFOXVLRQH[FOXVLRQFULWHULDZLOOEHHOLJLEOHWRHQUROOLQWKLV VWXG\
(DFKWUHDWPHQWF\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWRQFHGDLO\DWKRPHVWXG\PHGLFDWLRQ
DSSOLFDWLRQVIROORZHGE\ZHHNVRIIWUHDWPHQWZLWKDPD[LPXPRIWZRWUHDWPHQWF\FOHVDOORZHGIRUXSWRZHHNV
$W%DVHOLQHFRUUHVSRQGLQJWRWKH ILQDOVWXG\YLVLWRIWKHIHHG HUVWXG\WKHLQYHVWLJDWRUZLOO
SHUIRUPDFOLQLFDODVVHVVPHQWDQGGHWHUPLQHLIDQ\RIWKHVXEMH FWÂ¶VOHVLRQVUHTXLUHWUHDWPHQWXS
WR%6$,IWKHVXEMHFWKDVDFWLYHOHVLRQVDVGHWHUPLQHGE\ WKH,QYHVWLJDWRUÂ¶VFOLQLFDO
DVVHVVPHQWWKHVXEMHFWZLOOLQLWLDWHDF\FOHRIRQFHGDLO\DW KRPHVWXG\PHGLFDWLRQDSSOLFDWLRQ
WRWKHLU(%6OHVLRQVIRUZHHNVWUHDWPHQWSHULRGIROORZHGE\ DQZHHNSHULRGZKHUHQR
WUHDWPHQWZLOOEHDGPLQLVWHUHG6XEMHFWVSUHVHQWLQJZLWKQRDFW LYHOHVLRQVDVGHWHUPLQHGE\WKH
,QYHVWLJDWRUÂ¶VFOLQLFDODVVHVVPHQWZLOOQRWEHJLQWUHDWPHQWDQG LQVWHDGZLOOEHLQVWUXFWHGWRUHWXUQ
WRWKHFOLQLFIRUUHHYDOXDWLRQ LQZHHNVRUXSRQZRUVHQLQJRI (%6OHVLRQVZKLFKHYHUKDSSHQV
ILUVW
'XULQJWKHWUHDWPHQWSHULRGRIHDFKF\FOHVXEMHFWVFDUHJLYHUV ZLOODSSO\DWKLQOD\HURIWKH
DVVLJQHGVWXG\PHGLFDWLRQVXIILFLHQWWRFRYHUWKHVXEMHFWÂ¶V(% 6OHVLRQVDQGDSSUR[LPDWHO\Ã´
LQFKFPRIVXUURXQGLQJXQLQYROYHGVNLQDQGJHQWO\UXELQW KHVWXG\PHGLFDWLRQ
6XEMHFWVFDUHJLYHUVZLOODSSO\WKHDVVLJQHGVWXG\PHGLFDWLRQWR DOO(%6OHVLRQVLQFOXGLQJDQ\
QHZ(%6OHVLRQVWKDWGHYHORSXS WR%6$RQFHGDLO\HYHU\ HYHQLQJXQWLOWKHOHVLRQV
UHVROYHIRUZHHNV$IWHUZHHNVWKHVXEMHFWZLOOUHWXUQWR WKHVLWHWRUHWXUQWKHVWXG\
PHGLFDWLRQDQGUHPDLQRIIWUHDWPH QWIRUZHHNV7KHLQYHVWLJDW RUZLOOUHHYDOXDWHWKHVXEMHFW
DIWHUZHHNVRIIWKHUDS\DQGLIDQ\RIWKHVXEMHFWÂ¶VOHVLRQVU HTXLUHWUHDWPHQWXSWR%6$
WKHVXEMHFWZLOOEHJLQDQRWKHUWUHDWPHQWF\FOHIRUDPD[LPXPRI WZRWUHDWPHQWF\FOHVDOORZHG
IRUXSWRZHHNV
6DIHW\ZLOOEHPRQLWRUHGWKURXJKRXW WKHVWXG\E\UHSHDWHGFOLQL FDODQGODERUDWRU\HYDOXDWLRQV
YLWDOVLJQV(&*PRQLWRULQJDQGDGYHUVHHYHQWPRQLWRULQJ
(DFKWUHDWPHQWF\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWIROO RZHGE\ZHHNVRIIWUHDWPHQW
ZLWKDPD[LPXPRIWZRWUHDWPHQWF \FOHVDOORZHGIRUXSWRZHH NV6XEMHFWVVKRXOGEH
DVVHVVHGDWPLQLPXPHYHU\ZHHNVIRUGLVHDVHDFWLYLW\2QFHDVXEMHFWFRPSOHWHVWZRF\FOHVRI
WUHDWPHQWRUUHDFKHV:HHNWKH VXEMHFWZLOOEHGLVFKDUJHGIURPWKHVWXG\6XEMHFWVPD\QRW
VWDUWDQHZWUHDWPHQWF\FOHSDVW :HHNZLWKRXWSULRUVSRQVRU DSSURYDO7KHGXUDWLRQRID
VXEMHFWÂ¶VSDUWLFLSDWLRQLQWKHH [WHQVLRQVWXG\PD\EHDVVKRUW DVZHHNVRUDVORQJDVZHHNV
GHSHQGLQJRQWKHF\FOHLQLWLDWLRQVFKHGXOHIRUHDFKLQGLYLGXDO VXEMHFW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

6(/(&7,21',6326,7,212)678'<3238/$7,21
1XPEHURI6XEMHFWV
$SSUR[LPDWHO\VXEMHFWVDUHDQ WLFLSDWHGWREHHQUROOHGLQWKL VVWXG\DWDSSUR[LPDWHO\
LQWHUQDWLRQDOLQYHVWLJDWLRQDOFHQWHUV7KHDFWXDOQXPEHURIVXE MHFWVWKDWDUHHQUROOHGLQWRWKH
&&3VWXG\ZLOOGHSHQGRQWK HILQDOQXPEHURI(%6VXEMHF WVZKRSDUWLFLSDWHGLQWKH
&&3RU&&3VWXG\
6WXG\3RSXODWLRQ&KDUDFWHULVWLFV
6XEMHFWVHQUROOHGLQWKHH[WHQVLRQVWXG\ZLOOKDYHJHQHWLFFRQILUPDWLRQRI(%6YHULILHGLQWKH
IHHGHUVWXG\

,QFOXVLRQ&ULWHULD
,QRUGHUWREHHOLJLEOHIRUWKHVWXG\VXEMHFWVPXVWIXOILOODO ORIWKHIROORZLQJFULWHULD 
,QWKHRSLQLRQRIWKH,QYHVWLJDW RUWKHVXEMHFWLVFDSDEOHRIX QGHUVWDQGLQJDQGFRPSO\LQJ
ZLWKSURWRFROUHTXLUHPHQWV
7KHVXEMHFWRUZKHQDSSOLFDEOH WKHVXEMHFW
VOHJDOO\DFFHSWDE OHUHSUHVHQWDWLYHVLJQVDQG
GDWHVDZULWWHQLQIRUPHGFRQVHQWDVVHQWIRUPDQGDQ\UHTXLUHG SULYDF\DXWKRUL]DWLRQ
SULRUWRWKHLQLWLDWLRQRIDQ\VWXG\SURFHGXUHV
6XEMHFWKDVDGRFXPHQWHGJHQHWLF PXWDWLRQFRQVLVWHQWZLWK(%6
6XEMHFWVZKRSDUWLFLSDWHGLQ WKH&&3RUWKH&&3VWXG\DUHHOLJLEOHWREH
UROOHGLQWRWKH&&3RSHQO DEHOH[WHQVLRQVWXG\UHJDUGOHVVRIWKHLUFRPSOHWLRQ
VWDWXVRQWKHIHHGHUVWXG\
6XEMHFWFDUHJLYHUDJUHHVWRUHSRUWXVHRIDQ\WRSLFDOWKHUDSLHV DSSOLHGWR(%6OHVLRQV
HJPHGLFDWHGFOHDQVHUVEOHDFKFOHDQVHUVEOHDFKEDWKVWRSL FDODQWLVHSWLFVWRSLFDO
GLVLQIHFWDQWVHWF
,IWKHVXEMHFWLVDZRPDQRIFK LOGEHDULQJSRWHQWLDOVKHKDVD QHJDWLYHXULQHSUHJQDQF\
WHVWDQGDJUHHVWRXVHDQDSSURYH GHIIHFWLYHPHWKRGRIELUWKFR QWURODVGHILQHGE\WKLV
SURWRFROVHH6HFWLRQIRUWKHGXUDWLRQRIWKHVWXG\
6XEMHFWLVQRQODFWDWLQJDQGLVQRWSODQQLQJIRUSUHJQDQF\GXULQJWKHVWXG\SHULRG
6XEMHFWLVZLOOLQJDQGDEOHWRIROORZDOOVWXG\LQVWUXFWLRQVDQ GWRDWWHQGDOOVWXG\YLVLWV

([FOXVLRQ&ULWHULD
$Q\VXEMHFWZKRPHHWVRQHRUPRU HRIWKHIROORZLQJFULWHULDZLO OQRWEHLQFOXGHGLQWKLVVWXG\
6XEMHFWKDV(%6OHVLRQVWREHWUHDWHGWKDWDUHLQIHFWHG LH(%6OHVLRQVWKDWUHTXLUH
WRSLFDODQWLELRWLFWKHUDS\WRWUHDWDQLQIHFWLRQ
6XEMHFWKDVHYLGHQFHRIDV\VWHPL FLQIHFWLRQRUKDVXVHGV\VWHP LFDQWLELRWLFVZLWKLQ
GD\VSULRUWR%DVHOLQH
7KHVXEMHFWZDVGLVFRQWLQXHGIURP WKHIHHGHUVWXG\GXHWRDQDG YHUVHHYHQWMXGJHGWREH
UHODWHGRUSRVVLEO\UHODWHGWRWKHVWXG\PHGLFDWLRQ
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

6XEMHFWKDVH[SHULHQFHGDFKDQJHLQFOLQLFDOVWDWXVIURPWKHIH HGHUVWXG\WKDWLQWKH
LQYHVWLJDWRUÂ¶VRSLQLRQSXWVWKHVXEMHFWDWXQGXHULVNWRSDUWL FLSDWH
&RQFRPLWDQWWKHUDSLHV
&RQFRPLWDQWWKHUDSLHV DUHDQ\QHZRUH[LVWLQJRQJRLQJWKHUDS\U HFHLYHGIURP%DVHOLQHXQWLO
GLVFKDUJHIURPWKHVWXG\LQFO XGLQJWKHUDSLHVPRGLILHGIRUQRQ PHGLFDOUHDVRQVDQGWKHUDSLHV
XVHGIRUSURSK\OD[LV
&RQFRPLWDQWWKHUDSLHVLQFOXGHGUXJ HJSUHVFULSWLRQRYHUWKHF RXQWHU>27&@DQGQRQGUXJ
HJFKLURSUDFWLFSK\VLFDOWKHUDS\HQHUJ\EDVHGWUHDWPHQWV> HJODVHUVOLJKWEDVHGWKHUDS\@
WKHUDSLHV7KHXVHRIDQLQYHVWLJ DWRUDSSURYHGEODQGQRQPHGLF DWHGHPROOLHQWPRLVWXUL]HU
PHGLFDWHGFOHDQVHUVEOHDFKEDW KVWRSLFDODQWLVHSWLFVWRSLFDO GLVLQIHFWDQWVHWFPXVWEHUHSRUWHG
DVDFRQFRPLWDQWWKHUDS\LQWK HFDVHUHSRUWIRUPV&5)V
$OOQHZRUPRGLILHGFRQFRPLWDQWWKHUDSLHVXVHGGXULQJWKHVWXG\ PXVWEHUHFRUGHG
$Q\QHZRUPRGLILHGFRQFRPLWDQWW KHUDS\PXVWEHFRQVLGHUHGWRG HWHUPLQHLILWLVUHODWHGWRDQ
DGYHUVHHYHQW$($Q$(PXVWEH UHSRUWHGXQOHVVWKHWKHUDS\L VPRGLILHGIRUQRQPHGLFDO
UHDVRQVHJKHDOWKLQVXUDQFHSXUSRVHVRULWLVIRUSURSK\OD[LV HJYDFFLQDWLRQVWRSLFDO
DQHVWKHWLFVXVHGGXULQJEORRGVDPSOLQJ
3URKLELWHGWKHUDSLHV
6XEMHFWVZLOOEHSURKLELWHGIURPWDNLQJDQ\LQYHVWLJDWLRQDOSUR GXFWZLWKWKHH[FHSWLRQRI
'LDFHUHLQ2LQWPHQWWKURXJKRXWW KHLUSDUWLFLSDWLRQLQWKHVW XG\
,QIHFWHG/HVLRQV
(%6OHVLRQVWKDWEHFRPHLQIHFWHG LH(%6OHVLRQVWKDWUHTXLU HWKHUDS\WRWUHDWDQLQIHFWLRQ
GXULQJWKHFRXUVHRIWKHVWXG\VKRXOGEHPDQDJHGIROORZLQJWKH LQYHVWLJDWRUÂ¶VURXWLQHSUDFWLFH
DQGDOOFRQFRPLWDQWWKHUDSLHVUHSRUWHGLQWKHH&5)V1RVWXG\PHGLFDWLRQDSSOLFDWL RQVVKRXOGEHPDGHWRLQIHFWHGOHV LRQV,IDQ\(%6OHVLRQVDUHQRW
WUHDWHGZLWKVWXG\PHGLFDWLRQEHFDXVHWKH\DUHLQIHFWHGWKLVVLWXDWLRQPXVWEHQRWHGDVDQ
DGYHUVHHYHQW
6XEMHFW'LVFRQWLQXDWLRQIURPWKH6WXG\
6XEMHFWVFDUHJLYHUZLOOEHLQIRUPHGWKDWWKHVXEMHFWVDUHIUHH WRZLWKGUDZIURPWKHVWXG\DWDQ\
WLPHDQGIRUDQ\UHDVRQ
7KHLQYHVWLJDWRUPD\UHPRYHDVXE MHFWIURPWKHVWXG\LILQWKH LQYHVWLJDWRU
VRSLQLRQLWLVQRWLQ
WKHEHVWLQWHUHVWRIWKHVXE MHFWWRFRQWLQXHWKHVWXG\
([DPSOHVRIRWKHUUHDVRQVVXEMHFWVPD\EHGLVFRQWLQXHGIURPWKH VWXG\DUH
x$FKDQJHLQFRPSOLDQFHZLWKDQLQFOXVLRQRUH[FOXVLRQFULWHULRQ 
x2FFXUUHQFHRI$(V
x2FFXUUHQFHRISUHJQDQF\
x8VHRIDSURKLELWHGWKHUDS\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

x)DLOXUHWRPDLQWDLQWKHUHTXL UHGDSSOLFDWLRQIUHTXHQF\
x7KHVWXG\LVGLVFRQWLQXHGE\WKHVSRQVRU
,QFDVHRISUHPDWXUHGLVFRQWLQXDWLRQRIVWXG\SDUWLFLSDWLRQHIIRUWVZLOOEHPDGHWRSHUIRUPDOO
ILQDOVWXG\GD\DVVHVVPHQWV7KHGDWHWKHVXEMHFWLVZLWKGUDZQ IURPWKHVWXG\DQGWKHUHDVRQIRU
GLVFRQWLQXDWLRQZLOOEHUHFRUGHGRQWKHVXEMHFWÂ¶V&5)V$OOZLW KGUDZQVXEMHFWVZLWKRQJRLQJ
$(VZLOOEHIROORZHGDVDSSURSULDWH
7KHLQYHVWLJDWRUPXVWLPPHGLDWHO\ZLWKLQKRXUVQRWLI\WKH &DVWOH&UHHN3KDUPDFHXWLFDOV
//&DVVLJQHGVWXG\PRQLWRURIDVXEMHFWGLVFRQWLQXDWLRQ7KHVWXG\PD\EHGLVFRQWLQXHGDW WKHGLVFUHWLRQRI&DVWOH&UHHN 3KDUPDFHXWLFDOV//&6RPH
H[DPSOHVRIUHDVRQVIRUGLVFRQWL QXDWLRQDUHWKHRFFXUUHQFHRIW KHIROORZLQJ
x,QFUHDVHGIUHTXHQF\VHYHULW \RUGXUDWLRQRINQRZQ$(V
x0HGLFDOUHJXODWRU\RUHWKLFDOU HDVRQVDIIHFWLQJWKHFRQWLQXHG SHUIRUPDQFHRIWKH
VWXG\

6XEMHFW,GHQWLILHU6,
7KHLQYHVWLJDWRURUGHVLJQHHZ LOOUHJLVWHUHDFKVXEMHFWLQWKH &52,QF,QWHUDFWLYH5HVSRQVH
7HFKQRORJ\,57V\VWHPDW%DVHOLQHWRREWDLQD6,7KH6,IRUPDWZLOOEH11111ZKHUHWKHILUVWGLJLWVDUHWKHL QYHVWLJDWLRQDOFHQWHUVLWHQXPEHU
XVLQJOHDGLQJ]HURVDVDSSURSULDWH7KHILQDOGLJLWVDUHWK HVXEMHFWQXPEHU
7KHVXEMHFWZLOOEHLGHQWLILHGXVLQJWKH6,LQDOOVWXG\GRFXPH QWDWLRQIRUWKHGXUDWLRQRIWKH
VWXG\
,QVWUXFWLRQVIRUXVHRIWKH,57V\VWHPZLOOEHSURYLGHGWRHDFK LQYHVWLJDWRUSULRUWRWKHLQLWLDWLRQ
RIVXEMHFWHQUROOPHQWDWKHUKLVFHQWHU

5HSODFHPHQW6XEMHFWV
6XEMHFWHQUROOPHQWZLOOFRQWLQXHXQWLODOOVXEMHFWVZKRSDUWLFL SDWHLQWKH&&3VWXG\
DQGSDUWLFLSDWHLQWKH&&3 VWXG\DUHFRQVLGHUHGIRUHQU ROOPHQW6XEMHFWVZKRDUH
HQUROOHGLQWKLVVWXG\DQGGRQRWFRPSOHWHWKHVWXG\ZLOOQRWE HUHSODFHG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

,19(67,*$7,21$/3/$1
(DFKWUHDWPHQWF\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWIROO RZHGE\ZHHNVRIIWUHDWPHQW
ZLWKDPD[LPXPRIWZRWUHDWPHQWF \FOHVDOORZHGIRUXSWRRQH\H DU6XEMHFWVVKRXOGEHDVVHVVHG
DWPLQLPXPHYHU\ZHHNVIRUGLVHDVHDFWLYLW\2QFHDVXEMHFWF RPSOHWHVWZRF\FOHVRIWUHDWPHQW
RUUHDFKHV:HHNWKHVXEMHFWZLOOEHGLVFKDUJHGIURPWKHVWX G\6XEMHFWVPD\QRWVWDUWDQHZ
WUHDWPHQWF\FOHSDVW:HHNIURP%DVHOLQH9LVLWZLWKRXWSULRU VSRQVRUDSSURYDO7KHGXUDWLRQ
RIDVXEMHFWÂ¶VSDUWLFLSDWLRQLQWKHH[WHQVLRQVWXG\PD\EHDVV KRUWDVZHHNVRUDVORQJDV
ZHHNVGHSHQGLQJRQWKHF\FOHLQLWLDWLRQVFKHGXOHIRUHDFKLQGLY LGXDOVXEMHFW
6WXG\)ORZ&KDUW

9LVLWF %DVHOLQHD&\FOH6WDUWDF0LG&\FOHF(QGRI&\FOHF
6WXG\'D\:HHNDSSUR[LPDWH'D\ 'D\;'D\;
ZHHNV'D\;
ZHHNV
,QIRUPHG&RQVHQW$VVHQW ;
6XEMHFWLGHQWLILHU ;
,QFOXVLRQ	H[FOXVLRQ ;
'HPRJUDSKLFV	PHGLFDOKLVWRU\ ;
9LWDOVLJQV ;D;
&OLQLFDOODERUDWRU\VDPSOHV ;D;
(&* ;D;
3UHJQDQF\WHVWE ;D; ; ;
&OLQLFDO$VVHVVPHQW ;D; ; ;
'LVSHQVHFROOHFWVWXG\PHGLFDWLRQG; ; ;
6WXG\PHGLFDWLRQDSSOLFDWLRQH ;Ã†; Ã†
'LVSHQVHEOLVWHUODQFLQJNLW; ;
&RQFRPLWDQWWKHUDSLHV; ; ;
$GYHUVHHYHQWVI; ; ;
D5HVXOWVIURPIHHGHUVWXG\ZLOOEHXVHGDVGDWDSRLQWIRUWKLVH [WHQVLRQVWXG\DQGQHHGQRWEHUHSHDWHGXQOHVV
WKH'D\%DVHOLQHYLVLWLV!'D\VIURPWKH)LQDOYLVLWRIWKH IHHGHUVWXG\'D\%DVHOLQHPD\EHFRQVLGHUHGWKH
&\FOH6WDUW9LVLWLIWKHLQYHVWLJDWRUGHWHUPLQHVWKHVXEMHFWKD VOHVLRQVWKDWUHTXLUHWUHDWPHQW
E:2&%3RQO\
F$OOYLVLWVZLQGRZVDUHGD\VIURPWDUJHWGD\
G,QLWLDOVWXG\PHGLFDWLRQGLVSHQVD WLRQZLOOEHGHSHQGHQWRQOHVL RQDFWLYLW\RILQGLYLGXDOVXEMHFWÂ¶V(%6DQG
VKRXOGRQO\EHGLVSHQVHGLIWKHVXEMHFWPHHWVWUHDWPHQWFULWHUL DHJLIWKH,QYHVWLJDWRUGHWHUPLQHVQROHVLRQV
UHTXLUHWUHDWPHQWQRVWXG\PHGLFDWLRQZLOOEHGLVSHQVHG&ROO HFWLRQRIXVHGVWXG\PHGLFDWLRQZLOOEHJLQDWWKH
YLVLWIROORZLQJWKHILUVWGRVHRI VWXG\PHGLFDWLRQGLVSHQVDWLRQ 
H6WXG\PHGLFDWLRQDSSOLFDWLRQZLOOEHGHSHQGHQWRQOHVLRQDFWLYL W\RILQGLYLGXDOVXEMHFWÂ¶V(%6(DFKWUHDWPHQW
F\FOHZLOOFRQVLVWRIZHHNVRQWUHDWPHQWRQFHGDLO\DWKRPH VWXG\PHGLFDWLRQDSSOLFDWLRQVIROORZHGE\
ZHHNVRIIWUHDWPHQW6XEMHFWVZLOOEHUHTXLUHGWRUHFRUGWUHDWP HQWDSSOLFDWLRQDQGOHVLRQDFWLYLW\YLDWKHH'LDU\
I$WHDFKYLVLWWKH,QYHVWLJDWRUVKRXOGH[DPLQHWKHOHVLRQVEH LQJWUHDWHGIRUDQ\DGYHUVHHYHQWVVSHFLILFWR
WUHDWPHQW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

6WXG\9LVLWV'HVFULSW LRQDQG3URFHGXUHV
$ZULWWHQVLJQHGLQIRUPHGFRQVHQWIRUP,&)DQGDVVHQWIRUPD VDSSURSULDWHPXVWEHREWDLQHG
IURPHDFKVXEMHFWFDUHJLYHUSULRUWRSHUIRUPLQJDQ\VWXG\UHODW HGSURFHGXUH

'D\%DVHOLQH9LVLW
5HVXOWVIURPIHHGHUVWXG\ZLOOEHXVHGDVGDWDSRLQWIRUWKLVH [WHQVLRQVWXG\DQGQHHGQRWEH
UHSHDWHGXQOHVVWKH'D\%DVHOLQHYLVLWLV!'D\VIURPWKH)L QDOYLVLWRIWKHIHHGHUVWXG\$W
WKLVYLVLWWKHLQYHVWLJDWRURUGHVLJQHHZLOO
5HYLHZDQGH[SODLQWKHQDWXUHRIWKHVWXG\WRWKHVXEMHFWFDUHJ LYHUREWDLQWKH
VXEMHFWÂ¶VFDUHJLYHUÂ¶VVLJQDWXUHRQWKHDSSURSULDWHDSSURYHG,&) DVVHQWIRUPDV
DSSURSULDWHDQG+HDOWK,QVXUDQFH3RUWDELOLW\DQG$FFRXQWDELOLW\ $FW+,3$$
DXWKRUL]DWLRQ86VXEMHFWVRQO\ DQGSURYLGHDVL JQHGDQGGDWHGFRS\WRWKH
VXEMHFWFDUHJLYHU
&RQILUPWKHVXEMHFWPHHWVDOOLQFOXVLRQFULWHULDDQGQRH[FOXVL RQFULWHULRQ
5HJLVWHUVXEMHFWLQWKH,57V\VWHPWRREWDLQD6XEMHFW,GHQWLILFDWLRQQXPEHU
&ROOHFWGHPRJUDSKLFDQGPHGLFDOKLVWRU\LQIRUPDWLRQ
0HDVXUHYLWDOVLJQV
&ROOHFWEORRGDQGXULQHVDPSOHV IRUFOLQLFDOODERUDWRU\WHVWV
3HUIRUPDQ(&*
&ROOHFWXULQHSUHJQDQF\WHVWIRUDOOVXEMHFWVZKRDUHZRPHQRI FKLOGEHDULQJSRWHQWLDO
:2&%3WKHUHVXOWVPXVWEHQHJ DWLYHIRUWKHVXEMHFWWREHHQU ROOHGLQWKLVVWXG\
5HYLHZWKHH'LDU\LQVWUXFWLRQV
3HUIRUPD&OLQLFDO$VVHVVPHQW
D)RUVXEMHFWVZLWKOHVLRQVWKDWUH TXLUHWUHDWPHQWDVGHWHUPLQHG E\WKH,QYHVWLJDWRU
SURFHHGWR&\FOH6WDUW9LVLWDFWLYLWLHV
E)RUVXEMHFWVZLWKOHVLRQVWKDW GRQRWUHTXLUHWUHDWPHQWDVGHWH UPLQHGE\WKH
,QYHVWLJDWRUZKRDUHQRWLQLWLDWLQJVWXG\PHGLFDWLRQDSSOLFDWLR QV
L,QVWUXFWWKHVXEMHFWFDUHJLYHUWRFRQWDFWWKHLQYHVWLJDWRULIV KHKHIHHOV
WKHLU(%6KDVZRUVHQHG
LL6FKHGXOHWKHQH[WVWXG\YLVLWLQZHHNVRUXSRQZRUVHQLQJRIG LVHDVH
1RWHLIVXEMHFWUHWXUQVIRUWKHQH[WYLVLWDQGGRHVQRWPHHWF ULWHULD
IRULQLWLDWLQJF\FOHOHVLRQVUHTXLUHWUHDWPHQWWKHVLWHVKRXOGUHSHDW
VWHSE&\FOHVPD\RQO\VWDUW LIVXEMHFWKDVOHVLRQVWKDWUHT XLUH
WUHDWPHQWDVGHWHUPLQHGE\WKH,QYHVWLJDWRU 

&\FOH6WDUW9LVLW
1RWH'D\%DVHOLQHPD\EHFRQVLGHUHGWKH&\FOH6WDUW9LVLWLI VXEMHFWVKDYHOHVLRQVWKDW
UHTXLUHWUHDWPHQWDVGHWHUPLQHGE\WKH,QYHVWLJDWRU
)RUVXEMHFWVZLWKOHVLRQVWKDWUHTXLUHWUHDWPHQWZKRDUHLQLWLD WLQJWKHWUHDWPHQWSHULRG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

'LVSHQVHVWXG\PHGLFDWLRQDVDSSURSULDWH
5HYLHZWKHVWXG\PHGLFDWLRQDSS OLFDWLRQWHFKQLTXHZLWKWKHVXEMHFWFDUHJLYHU
3URYLGHD6XEMHFW,QVWUXFWLRQ6KHHW
'LVSHQVHDEOLVWHUODQFLQJNLWDQGLQVWUXFWLRQVWRWKHVXEMHFW FDUHJLYHULIQHHGHG
5HSRUWWKHVXEMHFWÂ¶VRQJRL QJFRQFRPLWDQWWKHUDSLHV
'RFXPHQWWKHVXEMHFWÂ¶VRQJRLQJD GYHUVHHYHQWVD OOHYHQWVFRQWLQXLQJIURPIHHGHUVWXGLHV
DQGDQ\QHZDGYHUVHHYHQWVPXVWEHUHSRUWHG
5HYLHZWKHVWXG\LQVWUXFWLRQVLQFOXGLQJH'LDU\ZLWKWKHVXEMH FWFDUHJLYHU
6FKHGXOHWKH0LG&\FOH9LVLWLQZHHNV

0LG&\FOH9LVLW
7KH0LG&\FOHYLVLWVKRXOGEHVFK HGXOHGZHHNVDIWHUWKH&\FOH 6WDUW9LVLW$IWHUWKLVYLVLWLV
SHUIRUPHGWKHVXEMHFWZLOOUHPDLQRIIWUHDWPHQWIRUZHHNV
$WWKLVYLVLWWKHLQYHVWLJDWRURUGHVLJQHHZLOOSHUIRUPWKHIR OORZLQJSURFHGXUHV
3HUIRUPDXULQHSUHJQDQF\WHVWIRUDOOVXEMHFWVZKRDUH:2&%3
3HUIRUPWKH&OLQLFDO$VVHVVPHQW
&ROOHFWDOOVWXG\PHGLFDWLRQ
'LVSHQVHDEOLVWHUODQFLQJNLWDQGLQVWUXFWLRQVWRWKHVXEMHFW FDUHJLYHULIQHHGHG
4XHU\WKHVXEMHFWFDUHJLYHUDERXWDQ\FKDQJHVLQWKHVXEMHFWÂ¶V FRQFRPLWDQWWKHUDSLHV
VLQFHWKHSUHYLRXVYLVLWDQGUHSRUWFKDQJHVRQWKHDSSURSULDWH IRUP
4XHU\WKHVXEMHFWFDUHJLYHULQDQRQGLUHFWLYHPDQQHUDERXWDQ\ FKDQJHVLQWKHVXEMHFWÂ¶V
KHDOWKVLQFHWKHSUHYLRXVYLVLWDQGUHSRUWDOO$(VRQWKHDSSUR SULDWHIRUP
&RQILUPWKHVXEMHFWFRQWLQXHVWRFRPSO\ZLWKDOOVWXG\UHVWULFW LRQVLVHOLJLEOHWRFRQWLQXH
LQWKHVWXG\DQGKDVIROORZHGDOOVWXG\LQVWUXFWLRQV
5HYLHZWKHVWXG\LQVWUXFWLRQVLQFOXGLQJH'LDU\ZLWKWKHVXEMH FWFDUHJLYHU
6FKHGXOHWKH(QGRI&\FOH9LVLWLQZHHNV

(QGRI&\FOH9LVLW
$IWHUWKHVXEMHFWKDVJRQHZHHN VZLWKRXWVWXG\PHGLFDWLRQWK HLQYHVWLJDWRUZLOOUHHYDOXDWH
WKHVXEMHFWDQGWRGHWHUPLQHLIWKHVXEMHFWLVHOLJLEOHWRLQLW LDWHDQRWKHUWUHDWPHQWF\FOH1RWH
VXEMHFWVPD\QRWVWDUWQHZWUHDWPHQWF\FOHSDVWZHHNZLWKRXW SULRUVSRQVRUDSSURYDO
$WWKLVYLVLWWKHLQYHVWLJDWRURUGHVLJQHHZLOO
0HDVXUHYLWDOVLJQV
&ROOHFWEORRGDQGXULQHVDPSOHV IRUFOLQLFDOODERUDWRU\WHVWV
3HUIRUPDQ(&*
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

3HUIRUPDXULQHSUHJQDQF\WHVWIRUDOOVXEMHFWVZKRDUH:2&%3
3HUIRUPD&OLQLFDO$VVHVVPHQW
D)RUVXEMHFWVZLWKOHVLRQVWKDWUH TXLUHWUHDWPHQWDVGHWHUPLQHG E\WKH,QYHVWLJDWRU
SURFHHGWR&\FOH6WDUW9LVLWDF WLYLWLHV1RWH2QFHDVXEMHFWF RPSOHWHVWZRF\FOHVRI
WUHDWPHQWRUUHDFKHV:HHNWKH VXEMHFWZLOOEHGLVFKDUJHGIURPWKHVWXG\6XEMHFWV
PD\QRWVWDUWDQHZWUHDWPHQWF\FOHSDVW:HHNZLWKRXWSULRU VSRQVRUDSSURYDO
E)RUVXEMHFWVZLWKOHVLRQVWKDW GRQRWUHTXLUHWUHDWPHQWDVGHWH UPLQHGE\WKH
,QYHVWLJDWRUZKRDUHQRWLQLWLDWLQJVWXG\PHGLFDWLRQDSSOLFDWLR QV
L,QVWUXFWWKHVXEMHFWFDUHJLYHUWRFRQWDFWWKHLQYHVWLJDWRULIV KHKHIHHOV
WKHLU(%6KDVZRUVHQHG
LL4XHU\WKHVXEMHFWFDUHJLYHUDERXWDQ\FKDQJHVLQWKHVXEMHFWÂ¶V
FRQFRPLWDQWWKHUDSLHVVLQFHWKH SUHYLRXVYLVLWDQGUHSRUWFKDQJ HVRQWKH
DSSURSULDWHIRUP
LLL4XHU\WKHVXEMHFWFDUHJLYHULQDQRQGLUHFWLYHPDQQHUDERXWDQ\ FKDQJHV
LQWKHVXEMHFWÂ¶VKHDOWKVLQFHWKHSUHYLRXVYLVLWDQGUHSRUWDOO $(VRQWKH
DSSURSULDWHIRUP
LY&RQILUPWKHVXEMHFWFRQWLQXHVWRFRPSO\ZLWKDOOVWXG\UHVWULFWLRQVLVHOLJLEOHWRFRQWLQXHLQWKHVWXG \DQGKDVIROORZHGDOOVWXG\LQVWUXFWLRQV
LQFOXGLQJH'LDU\
Y6FKHGXOHWKHQH[WVWXG\YLVLWLQZHHNVRUXSRQZRUVHQLQJRIG LVHDVH
1RWHLIVXEMHFWUHWXUQVIRUWKHQH[WYLVLWDQGGRHVQRWPHHWF ULWHULD
IRULQLWLDWLQJF\FOHOHVLRQVUHTXLUHWUHDWPHQWWKHVLWHVKRXOGUHSHDWVWHSE&\FOHVPD\RQO\VWDUWL IVXEMHFWKDVOHVLRQVWKDWUHTX LUHPHQW
WUHDWPHQWDVGHWHUPLQHGE\WKH,QYHVWLJDWRU

(%6/HVLRQ,GHQWLILFDWLRQ
)RUWKLVVWXG\DQ(%6OHVLRQLVGHILQHGDVDEOLVWHU LHDIOXLGILOOHGWKLQZDOOHGVWUXFWXUHRU
WKHFUXVWDQGRUHURVLRQDULVLQJIURPDSUHYLRXVEOLVWHUDQGWKHLPPHGLDWHO\VXUURXQGLQJLQWHQVH
HU\WKHPD,QYHVWLJDWRUVZLOOXVHFOLQLFDOMXGJPHQWWRGHWHUPLQH LIWKH(%6OHVLRQUHTXLUHV
WUHDWPHQW,QYHVWLJDWRUVDUHHQFRXUDJHGWRDVVHVVWKHRYHUDOOV HYHULW\RIOHVLRQVHJEOLVWHUV
HURVLRQVFUXVWLQJHU\WKHPDDQG RUSLJPHQWDU\FKDQJHVWRGHWH UPLQHZKLFKOHVLRQVUHTXLUH
WUHDWPHQW
6XEMHFW,QVWUXFWLRQV
$QLQYHVWLJDWLRQDOFHQWHUVWDIIPHPEHUZLOOSURYLGHDVXEMHFWL QVWUXFWLRQVKHHWWRHDFK
VXEMHFWFDUHJLYHUWRKHOSZLWKFRPSOLDQFHWRWKHVWXG\UHTXLUHP HQWV8SGDWHGLQIRUPDWLRQDQG
LQVWUXFWLRQIRUVXEMHFWVZLOOEHSURYLGHGDVQHFHVVDU\
7KURXJKRXWWKHVWXG\WKHVXEMHFWVVKRXOG
x&RQWLQXHWKHLUURXWLQHFRVPH WLFVDQGVNLQFDUHSURGXFWV
x%OHDFKPHGLFDWHGFOHDQVHUVEOHD FKEDWKVWRSLFDODQWLVHSWLFV WRSLFDOGLVLQIHFWDQWV
HWFDUHDOORZHGDQGGH WDLOVRIXVHPXVWEHUHSRUWHGWRWKHVLW H
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

x$YRLGH[SRVLQJWKHWUHDWHG(%6O HVLRQVWRH[FHVVLYHQDWXUDORU DUWLILFLDOXOWUDYLROHW
UDGLDWLRQ HJVXQOLJKWWDQQLQJEHGVDQGXVH VXQVFUHHQRQWKHOHVLRQVLI H[FHVVLYH
H[SRVXUHFDQQRWEHDYRLGHG
x2QO\XVHDWXEHRIVWXG\PHGLFDWLRQIRUDPD[LPXPRIGD\VD IWHUGD\VKDV
HODSVHGIURPGDWHRIRSHQLQJDQ HZWXEHRIPHGLFDWLRQVKRXOGE HRSHQHG
x$SSO\VWXG\PHGLFDWLRQVWROHVL RQVLGHQWLILHGE\WKH,QYHVWLJDW RUWKDWUHTXLUH
WUHDWPHQW
x$SSO\VWXG\PHGLFDWLRQGDLO\LQWKHHYHQLQJXQWLOOHVLRQVUHV ROYHIRUXSWRZHHNV
x$SSO\VWXG\PHGLFDWLRQGDLO\LQWKHHYHQLQJWRDQ\QHZOHVLRQ VWKDWDSSHDULQ
EHWZHHQVWXG\YLVLWVXSWR%6$XQWLOOHVLRQVUHVROYHIRU XSWRZHHNV
x)ROORZWKHLQVWUXFWLRQVIRUEOLVWHUODQFLQJPDQDJHPHQWDQGFDUH 
x%ULQJWKHVXEMHFWLQVWUXFWLRQVKHHWDQGDOOVWXG\PHGLFDWLRQWX EHVZLWKWKHPWRHDFK
PLGF\FOHYLVLW

(%6/HVLRQ&DUH
%OLVWHUODQFLQJNLW
$QLQYHVWLJDWLRQDOFHQWHUVWDIIPHPEHUZLOOGLVSHQVHDQRSWLRQD OEOLVWHUODQFLQJNLWVDQG
LQVWUXFWLRQVWRHYHU\VXEMHFWFDUHJLYHUDVDSSURSULDWH7KHVXE MHFWZLOOEHLQVWUXFWHGWRODQFHDOO
(%6OHVLRQVLQFOXGLQJVWXG\PHGLFDWLRQWUHDWHGOHVLRQVDQGWKR VHQRWWUHDWHGZLWKVWXG\
PHGLFDWLRQ HJOHVLRQVH[FHHGLQJ%6$Z LWKLQKRXUVRIDSSHDUDQFH
%OLVWHUODQFLQJNLWVDQGZULWWHQLQVWUXFWLRQVIRUXVHRIWKHNL WVZLOOEHSURYLGHGWRHDFK
LQYHVWLJDWLRQDOFHQWHUSULRUWRWKHLQLWLDWLRQRIVXEMHFWHQURO OPHQW

%DQGDJLQJ'UHVVLQJ8VH
%DQGDJLQJRI(%6OHVLRQVLVQRWSURKLELWHGGXULQJWKLVVWXG\6 XEMHFWVVKRXOGEHHQFRXUDJHGWR
UHPDLQFRQVLVWHQWZLWKWKHLUEDQGDJLQJURXWLQHKRZHYHUWKLVL VQRWUHTXLUHG%DQGDJLQJVKRXOG
EHUHFRUGHGLQWKHH&5)DVDFRQFRPLWDQWWKHUDS\
1RWH$OOEDQGDJLQJLVSURKLELWHGIRUWKHILUVWKRXUDIWHUVWXG \PHGLFDWLRQDSSOLFDWLRQ

6WXG\'XUDWLRQ
7KHGXUDWLRQRIVWXG\SDUWLFLSDWLRQIRUDVXEMHFWLVDQWLFLSDWH GWREHDPD[LPXPRIZHHNVDQG
GD\VRUWUHDWPHQWF\FOHVZKLFKHYHULVVKRUWHU6XEMHFWVPD \QRWLQLWLDWHDQHZWUHDWPHQW
F\FOHEH\RQG:HHNZLWKRXWSULRUVSRQVRUDSSURYDO7KHVWXG\HQGGDWHLVWKHGDWHRIWKHODVWVXEMHFWÂ¶VODVWVWXG\ YLVLW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

6WXG\0HGLFDWLRQV
6WXG\PHGLFDWLRQLGHQWLW\
7KHVWXG\PHGLFDWLRQLVD\HOORZVWHULOHRLQWPHQW7KHVWXG\PH GLFDWLRQPXVWEHVWRUHGLQD
VHFXUHGDUHDZLWKOLPLWHGDFFHVVXQGHUDSSURSULDWHO\FRQWUROOHG DQGPRQLWRUHGVWRUDJH
FRQGLWLRQV



6WXG\0HGLFDWLRQ,QIRUPDWLRQ
6WXG\PHGLFDWLRQQDPH 'LDFHUHLQ&&32LQWPHQW6WHULOH
0DQXIDFWXUHU 7:L3KDUPDFHXWLFDOV,QF 7DR\XDQ&LW\7DLZDQ
'LDFHUHLQFRQFHQWUDWLRQ 
3KDUPDFHXWLFDO)RUP 2LQWPHQW
6WRUDJH&RQGLWLRQV Âƒ)WRÂƒ)Âƒ&WRÂƒ&
'RVHUHJLPHQ 
5RXWH 7RSLFDO
)UHTXHQF\ 2QFHGDLO\DSSOLFDWLRQWRDOO(%6OHVLRQV
'XUDWLRQRIDGPLQLVWUDWLRQ2QFHGDLO\DSSOLFDWLRQVIRUDPD[LPXPRIZHHNVLQD
VLQJOHWUHDWPHQWF\FOH

6WXG\PHGLFDWLRQIRUPXODWLRQ



'LDFHUHLQ
&&3
2LQWPHQW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

6WXG\PHGLFDWLRQSDFNDJLQJDQGODEHOLQJ
7KHVWXG\PHGLFDWLRQLVD\HOORZFRORUHGVWHULOHRLQWPHQWDQGZLOOEHSDFNDJHGLQDOXPLQXP
WXEHVWKDWHDFKFRQWDLQDPLQLPXPRIJUDPVRIVWXG\PHGLFDWL RQ
$EXONVXSSO\RI'LDFHUHLQ2LQWPHQWVWXG\PHGLFDWLRQZLWKRQHWXEHLQHDFKFDUWRQZLOOEHSURYLGHGWRHDFKLQYHVWLJDWLRQDOFHQWHU$VXIILFLHQWVXSSO\RI VWXG\PHGLFDWLRQZLOOEHSURYLGHG
WRHDFKVLWHSULRUWRWKHLQLWLDWL RQRIVXEMHFWHQUROOPHQWDQG UHSOHQLVKHGDVQHHGHG
(DFKVWXG\PHGLFDWLRQFDUWRQZLOOEHODEHOHGZLWKDRQHSDUWOD EHOWKDWLVFRPSOHWHGZKHQWKH
WXEHLVGLVSHQVHGUHPDLQVDWWDFKHGWRWKHFDUWRQ
7KHFDUWRQODEHOVKRZVDWOHDVWWKHIROORZLQJ
x3URWRFROQXPEHU
x7XEHQXPEHU
x6WXG\PHGLFDWLRQLGHQWLW\
x,QYHVWLJDWLRQDOGUXJZDUQLQJ
x6SDFHWRHQWHUWKH6,
(DFKVWXG\PHGLFDWLRQWXEHZLOOEHODEHOHGZLWKDWZRSDUWODEH O%RWKSDUWVRIWKHODEHODUH
FRPSOHWHGZKHQWKHWXEHLVGLVSH QVHGRQHSDUWRIWKHFRPSOHWHG ODEHOUHPDLQVDWWDFKHGWRWKH
WXEHWKHRWKHUSDUWWHDURII LVVHSDUDWHGDQGDWWDFKHGWRWK HVXEMHFWÂ¶VGUXJDFFRXQWDELOLW\ORJ
%RWKSDUWVRIWKHFDUWRQODEHOVKRZDWOHDVWWKHIROORZLQJ
x3URWRFROQXPEHU
x7XEHQXPEHU
x6WXG\PHGLFDWLRQLGHQWLW\
x6WRUDJHFRQGLWLRQV
x,QVWUXFWLRQVIRUXVH
x6SRQVRULQIRUPDWLRQ
x,QYHVWLJDWLRQDOGUXJZDUQLQJ
x6SDFHWRHQWHUWKH6,
x6SDFHWRHQWHUWKHGDWHGLVSHQVHG
0HWKRGRIWUHDWPHQWDVVLJQPHQW
$OOVXEMHFWVZLOOEHDVVLJQHGWRUHFHLYH'LDFHUHLQ2LQWPHQW 

6XEMHFWWUHDWPHQWDVVLJQPHQW
$WWKHVWXG\YLVLWZKHQDVXEMHFWLQLWLDWHVDWUHDWPHQWF\FOHWKHLQYHVWLJDWRURUGHVLJQHHZLOO
HOHFWURQLFDOO\FRQWDFWWKH,57V\VWHPWRLGHQWLI\WKHWXEHQXPE HUVWREHGLVSHQVHGWRWKH
VXEMHFW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

,QVWUXFWLRQVIRUXVHRIWKH,57V\VWHPZLOOEHSURYLGHGWRHDFK LQYHVWLJDWRUSULRUWRWKHLQLWLDWLRQ
RIVXEMHFWHQUROOPHQWDWKHUKLVFHQWHU
'LVSHQVLQJVWXG\PHGLFDWLRQ
7KHVWXG\PHGLFDWLRQPXVWEHGLVSHQVHGRQO\WRVWXG\VXEMHFWV RQO\DWLQYHVWLJDWLRQDOFHQWHUV
VSHFLILHGRQWKH)RUP)'$R ULWVHTXLYDOHQWDQGRQO\E\ DXWKRUL]HGSHUVRQQHODVUHTXLUHG
E\DSSOLFDEOHUHJXODWLRQVDQGJXLGHOLQHV
7KHVXEMHFWFDUHJLYHUPXVWEULQJ GLVSHQVHGVWXG\PHGLFDWLRQWXEHVDQGLISRVVLEOHFDUWRQVZLWK
WKHPWRDOOYLVLWV
$WDVWXG\YLVLWZKHQDVXEMHFWL VHOLJLEOHWREHGLVSHQVHGVWX G\PHGLFDWLRQDQGWKHDVVLJQHG
VWXG\PHGLFDWLRQWXEHVKDYHEHHQ LGHQWLILHGDQLQYHVWLJDWLRQDO FHQWHUVWDIIPHPEHUZLOO
FRPSOHWHWKHODEHOVDQGGLVSHQVH WKHWXEHWRWKHVXEMHFWFDUHJL YHU
$WDOODSSOLFDEOHYLVLWVH[DPLQHWKHWXEHVRIVWXG\PHGLFDWL RQGLVSHQVHGWRWKH
VXEMHFWFDUHJLYHU8QRSHQHGWXEHVSUHYLRXVO\GLVSHQVHGFDQEHU HGLVSHQVHGWRD
VXEMHFWFDUHJLYHU
$WWKHHQGRIDWUHDWPHQWSHUL RGDOOVWXG\PHGLFDWLRQWXEHVZL OOEHFROOHFWHGIURPWKH
VXEMHFWFDUHJLYHU
7KHLQYHVWLJDWLRQDOFHQWHUVWD IIVKRXOGPDNHHYHU\HIIRUWWRREWDLQDOOGLVSHQVHGDQGXQXVHG
VWXG\PHGLFDWLRQ7ZRGRFXPHQWH GWHOHSKRQHFRQWDFWVIROORZHGE\ DUHJLVWHUHGOHWWHUWRWKH
VXEMHFWFDUHJLYHUDUHDGHTXDWHIROORZXSHIIRUWV,IWKHVHHIIR UWVIDLOWKHUHDVRQIRUWKHIDLOXUH
PXVWEHQRWHGLQWKH&5)$OOXQXVHGDQGXQGLVSHQVHGVWXG\PHG LFDWLRQVKRXOGEHKHOGIRU
LQVSHFWLRQE\WKHPRQLWRU8SRQFRPSOHWLRQRIWKHVWXG\DOOVW XG\PHGLFDWLRQZLOOEHUHWXUQHGWR
&DVWOH&UHHN3KDUPDFHXWLFDOV//&RUDGHVLJQDWHGWKLUGSDUW\E \WKHPRQLWRUXVLQJDWUDFHDEOH
PHWKRG

6WXG\PHGLFDWLRQDSSOLFDWLRQ
7KHVWXG\PHGLFDWLRQLVIRUH[WHU QDOWRSLFDOXVHRQWKHVXEMHF WÂ¶V(%6OHVLRQVRQO\

$WWKHVWXG\YLVLWZKHUHDVXEMHFWLQLWLDWHVWUHDWPHQWIRUWKHILUVWWLPHRQWKHVWXG\DQ
LQYHVWLJDWLRQDOFHQWHUVWDIIPHPEHUZLOOUHYLHZWKHDSSURSULDWH DSSOLFDWLRQWHFKQLTXHZLWKWKH
VXEMHFWFDUHJLYHU
7RSHUIRUPDVWXG\PHGLFDWLRQDSSOLFDWLRQWKHVXEMHFWFDUHJLYH UVKRXOG
x:DVKKHUKLVKDQGVEHIRUHVWDUWLQJWKHDSSOLFDWLRQ
x$SSO\VXIILFLHQWTXDQWLW\RIWKHDVVLJQHGVWXG\PHGLFDWLRQWRF RYHUDOO(%6OHVLRQV
DQGWRDERXWÃ´LQFKFPRIXQLQYROYHGVNLQVXUURXQGLQJHDFKOHVLRQZLWKDWKLQ
OD\HUDQGJHQWO\UXELWLQ
x$JHQHUDOUXOHWRIROORZLVILQJHUWLSXQLWRIVWXG\PHGLFDWLR QLVVXIILFLHQWWRFRYHU
DSSUR[LPDWHO\%6$SDOPDUPH WKRGPHDVXUHPHQWIRUWKDWSDUW LFXODUVXEMHFW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

x1RWFRYHUWKHWUHDWHGDUHDZLWKDQ\W\SHRIEDQGDJHRUGUHVVLQJ IRUKRXUDIWHUWKH
DSSOLFDWLRQ
x:DVKKHUKLVKDQGVDIWHUFRPSOHWLQJWKHDSSOLFDWLRQ
(DFKRSHQHGWXEHRIVWXG\PHGLFDWLRQFDQRQO\EHXVHGIRUGD \V$QHZWXEHRIVWXG\
PHGLFDWLRQVKRXOGQRWEHRSHQHG XQWLOWKHILUVWWXEHLVHLWKHUHPSW\RUKDVEHHQRSHQIRU!
GD\V
7KHVXEMHFWFDUHJLYHUZLOOFRQWLQXHRQFHGDLO\DSSOLFDWLRQVWR HYHU\DFWLYHHJQRWKHDOHG(%6
OHVLRQLQWKHHYHQLQJXQWLOWKHOHVLRQVUHVROYHIRUWKHZHH NWUHDWPHQWSHULRG
$WDOOWUHDWPHQWSHULRGYLVLWVDVWDIIPHPEHUZLOOUHYLHZWKH DSSOLFDWLRQWHFKQLTXHZLWKWKH
VXEMHFWVFDUHJLYHUVWRFRQILUPLWLVEHLQJSURSHUO\SHUIRUPHG
1HZ(%6OHVLRQVXSWR%6$WKDWGHYHORSGXULQJDWUHDWPHQW SHULRGDIWHUF\FOHVWDUWEXW
SULRUWRF\FOHHQGVKRXOGEHWUHDWHGRQFHGDLO\ZLWKVWXG\PHG LFDWLRQXQWLOUHVROYHG
(%6OHVLRQVWKDWDUHH[FOXGHGIURPWUHDWPHQWZLWKWKHVWXG\PHG LFDWLRQHJWKRVHH[FHHGLQJ
%6$PD\EHWUHDWHGIROORZLQJVWDQGDUGRIFDUH
'RVHFRPSOLDQFHUHFRUG
(DFKVXEMHFWFDUHJLYHUZLOOUHFRUGWKHVXEMHFWÂ¶VFRPSOLDQFHZLW KWKHVWXG\PHGLFDWLRQ
DSSOLFDWLRQIUHTXHQF\RQDGDLO\ EDVLVLQDQH'LDU\6XEMHFWVF DUHJLYHUVZLOODOVREHUHTXLUHGWR
UHSRUWDQ\QHZ(%6OHVLRQVWKDW UHTXLUHWUHDWPHQWWKDWGHYHORS LQEHWZHHQVWXG\YLVLWVXVLQJWKH
H'LDU\6XEMHFWVFDUHJLYHUVZLOOEHUHTXLUHGWRUHSRUWDGKHUHQF HWREOLVWHUODQFLQJ
UHFRPPHQGDWLRQVXVLQJWKHH'LDU\
'RVHPRGLILFDWLRQ
6XEMHFWVFDUHJLYHUVVKRXOGQRWPRGLI\WKHVWXG\PHGLFDWLRQDSSOLFDWLRQSURFHGXUHRUIUHTXHQF\
ZLWKRXWDSSURYDOIURPWKHLQYHVWLJDWRURUGHVLJQHH
,IDQ\VLJQLILFDQWVWXG\PHGLFDWL RQLQWROHUDQFHRUVDIHW\LVVXH RFFXUVWKHLQYHVWLJDWRURUGHVLJQHH
PD\GLUHFWWKHVXEMHFWFDUHJLYHUWRUHGXFHWKHVWXG\PHGLFDWLRQ DSSOLFDWLRQIUHTXHQF\DV
GHWHUPLQHGE\WKHLQYHVWLJDWRU0RGHUDWHWRVHYHUHGLDU[LOCATION_006]HDKDV EHHQREVHUYHGLQVRPHSDWLHQWV DGPLQLVWHUHGRUDOGLDFHUHLQIRU
WKHWUHDWPHQWRIRVWHRDUWKULWLV
x0RGHUDWHGLDU[LOCATION_006]HD ZDWHU\VWRROVSHUGD\
x6HYHUHGLDU[LOCATION_006]HD!ZDWHU\VWRROVSHUGD\
6WXG\PHGLFDWLRQDSSOLFDWLRQVV KRXOGEHGLVFRQWLQXHGLIWKHVXE MHFWH[SHULHQFHVPRGHUDWHRU
VHYHUHGLDU[LOCATION_006]HD6WXG\PHGLFDWLRQVKRXOGDOVREHGLVFRQWLQXHGLIWKHVXEMHFWH[SHULHQFHVDQ\LQVWDQFHRIGLDU[LOCATION_006]HD
ZLWKEOHHGLQJDQGWKHUHLVQRFOHDUPHGLFDOUDWLRQDOHIRUWKHR FFXUUHQFH
7KHGLDU[LOCATION_006]HDPXVWEHUHSRUWHGDVDQDGYHUVHHYHQWLQWKH&5)7 KHVHVXEMHFWVVKRXOGEH
ZLWKGUDZQIURPWKHVWXG\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

6WXG\PHGLFDWLRQ0DQDJHPHQW
$FFRXQWDELOLW\
7KHLQYHVWLJDWRURUGHVLJQHHZLOOPDLQWDLQDQDFFXUDWHUHFRUGR IWKHUHFHLSWRIWKHVWXG\
PHGLFDWLRQVDVVKLSSHGE\&DVWOH &UHHN3KDUPDFHXWLFDOV//&RUGHVLJQHHLQFOXGLQJWKHGDWH
UHFHLYHGDQGWKHFRQGLWLRQRIWKH VWXG\PHGLFDWLRQV2QHFRS\RIWKLVUHFHLSWZLOOEHUHWXUQHGWR
&DVWOH&UHHN3KDUPDFHXWLFDOV//&ZKHQWKHFRQWHQWVRIWKHVWXG \PHGLFDWLRQVKLSPHQWKDYH
EHHQYHULILHGDQGRQHFRS\PDLQW DLQHGLQWKHVWXG\ILOH,QDGG LWLRQDQDFFXUDWHVWXG\
PHGLFDWLRQGLVSRVLWLRQUHFRUGZLOOEHNHSWVSHFLI\LQJWKHDPRX QWGLVSHQVHGWRHDFK
VXEMHFWFDUHJLYHUDQGWKHGDWHR IGLVSHQVLQJ7KLVLQYHQWRU\UH FRUGZLOOEHDYDLODEOHIRU
LQVSHFWLRQDWDQ\WLPH$WWKHFRPSOHWLRQRIWKHVWXG\WKHRUL JLQDOLQYHQWRU\UHFRUGZLOOEH
DYDLODEOHIRUUHYLHZE\&DVWOH&UHHN3KDUPDFHXWLFDOV//&XSRQ UHTXHVW
5HWXUQDQGGLVSRVLWLRQRIVWXG\VXSSOLHV
$WWKHFRPSOHWLRQRIWKHVWXG\DOOXQXVHGVWXG\PHGLFDWLRQZLO OEHUHWXUQHGWR&DVWOH&UHHN
3KDUPDFHXWLFDOV//&RUGHVLJQHHIRUGLVSRVDOSHU&DVWOH&UHH N3KDUPDFHXWLFDOV//&Â¶VRU
GHVLJQHHÂ¶VZULWWHQLQVWUXFWLRQV

%OLQGLQJ
9HULILFDWLRQRIEOLQGLQJ
7KLVLVDQRSHQODEHOVWXG\WKHVWXG\PHGLFDWLRQLGHQWLW\LVN QRZQWRERWKWKHVXEMHFWDQGWKH
LQYHVWLJDWRU
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

678'<$66(660(176
6DIHW\(YDOXDWLRQV
,QDGGLWLRQWRUHSRUWLQJDGYHUVHHYHQWVWKURXJKRXWWKHVWXG\WK HLQYHVWLJDWRUDGHVLJQDWHGDQG
DSSURSULDWHO\WUDLQHGVWDIIPHPEHURUWKHVXEMHFWFDUHJLYHUZL OOSHUIRUPWKHIROORZLQJVDIHW\
DVVHVVPHQWVDFFRUGLQJWRWK HVFKHGXOHVQRWHGEHORZ
'HPRJUDSKLFV0HGLFDO+LVWRU\
$WWKHWLPHSRLQWVVSHFLILHGLQ WKH6WXG\)ORZ&KDUWWKHLQYHVW LJDWRURUGHVLJQHHZLOOLQWHUYLHZ
HDFKVXEMHFWFDUHJLYHUWRREWDLQGHPRJUDSKLFLQIRUPDWLRQLQFOXG LQJGDWHRIELUWKVH[DWELUWK
UDFHDQGHWKQLFLW\
0HGLFDOKLVWRU\LQIRUPDWLRQZLOOEHUHFRUGHGLQFOXGLQJDOOPHGL FDOFRQGLWLRQVDQGGLVHDVHVWDWHV
WKDWDW%DVHOLQH
x$UHRQJRLQJ
x5HTXLUHFRQFRPLWDQWWKHUDS\
x$UHLQWKHRSLQLRQRIWKHLQYHV WLJDWRUUHOHYDQWWRWKHVXEMHF WÂ¶VVWXG\SDUWLFLSDWLRQ
9LWDO6LJQV
$WWKHWLPHSRLQWVVSHFLILHGLQ WKH6WXG\)ORZ&KDUWDTXDOLILH GVWDIIPHPEHUZLOOPHDVXUHHDFK
VXEMHFWÂ¶VYLWDOVLJQV7KHIROORZLQJLWHPVZLOOEHPHDVXUHG
x%RG\WHPSHUDWXUH
x3XOVHUDWH
x5HVSLUDWLRQUDWH
x%ORRGSUHVVXUHV\VWROLFDQGGLDV WROLFDIWHUWKHVXEMHFWVLWV TXLHWO\IRUDWOHDVW
PLQXWHV
x+HLJKW
x:HLJKW
7KHYLWDOVLJQVFROOHFWHGIURPWKHIHHGHUVWXGLHVILQDOYLVLW ZLOOEHXVHGDVWKH%DVHOLQHGDWDIRU
WKLVVWXG\DQGQHHGQRWEHUHSHDWHGXQOHVVWKHYLVLWRFFXUVRXW VLGHWKHZLQGRZDOORZHGLQWKH
6WXG\)ORZ&KDUW
&OLQLFDOODERUDWRU\VDPSOLQJ
$WWKHWLPHSRLQWVVSHFLILHGLQ WKH6WXG\)ORZ&KDUWDTXDOLILH GVWDIIPHPEHUZLOOFROOHFWEORRG
DQGXULQHVDPSOHVIRUFOLQLFDOODERUDWRU\DQDO\VLV7RSLFDODQH VWKHWLFVPD\EHXVHGGXULQJWKH
EORRGVDPSOHFROOHFWLRQ,IXVHGWKHWRSLFDODQHVWKHWLFVVKRXO GEHUHSRUWHGDVDFRQFRPLWDQW
WKHUDS\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

7KHUHVXOWVRIWKHIHHGHUVWXGLHVILQDOYLVLWFOLQLFDOODERUD WRU\VDPSOHVZLOOEHXVHGDVWKH
%DVHOLQHGDWDIRUWKLVVWXG\DQGQHHGQRWEHUHSHDWHGXQOHVVWK HYLVLWRFFXUVRXWVLGHWKHZLQGRZ
DOORZHGLQWKH6WXG\)ORZ&KDUW
7KHIROORZLQJWHVWVZLOOEHSHUIRUPHG

&KHPLVWU \3DQHO &RPSOHWH%ORRG&RXQ W
$OEXPLQ +HPDWRFULW
$ONDOLQHSKRVSKDWDVH$/3 +HPR JORELQ
$ODQLQHDPLQRWUDQVIHUDVH$/7 3ODWHOHWFRXQW
$P\ODVH 5HGEORRGFHOOPRUSKROR J\
$VSDUWDWHDPLQRWUDQVIHUDVH$67 5HGEORRGFHOOFRXQW%ORRGXUHDQLWUR
JHQ%81 :KLWHEORRGFHOOFRXQW
%LFDUERQDWH :KLWHEORRGFHOOGLIIHUHQWLDO
&KORULGH DQGDEVROXWH
&UHDWLQLQH %DVRSKLOV
*D[COMPANY_003]*OXWDP\O7UDQVIHUDVH
**7
*OXFRVH (RVLQRSKLOV
+E$F /\PSKRF\WHV
/DFWDWHGHK \GURJHQDVH/'+ 0RQRF \WHV
/LSDVH 1HXWURSKLOV
3RWDVVLXP 
6RGLXP &RPSOHWH8ULQDO\VLV
7RWDOELOLUXELQ 
7RWDOSURWHLQ 
8ULFDFLG 
7KHUHVXOWVRIWKHFOLQLFDOODERUDWRU\WHVWVZLOOEHUHSRUWHGRQWKHODERUDWRU\Â¶VVWDQGDUGUHSRUWV
7KHLQYHVWLJDWRURUGHVLJQHHPXVWUHYLHZDOOODERUDWRU\UHSRUWV LQDWLPHO\PDQQHUDQGQRWH1&5
RU&5WRGHILQHWKHFOLQLFDOUHOHYDQFHRIDQ\UHVXOWWKDWLVRXWVLGHWKHQRUPDOUDQJHIRUWKHODERUDWRU\7KHLQYHVWLJDWRURUGHVLJQHHPXVWGDWHDQGLQLWLDO HYHU\ODERUDWRU\UHSRUW
7KHLQYHVWLJDWRUPXVWUHSRUWDOOODERUDWRU\UHVXOWVWKDWDUH%2 7+RXWVLGHWKHQRUPDOUDQJHIRU
WKHODERUDWRU\$1'LQWKHRSLQ LRQRIWKHLQYHVWLJDWRU&5DVP HGLFDOKLVWRU\LIIRXQGSULRUWR
WKHILUVWVWXG\PHGLFDWLRQWUHDW PHQWRUDVDQ$(LIIRXQGDIWHUWKHILUVWVWXG\PHGLFDWLRQ
WUHDWPHQWEHJLQV
(OHFWURFDUGLRJUDP(&*0RQLWRULQJ
6LQJOHOHDG(&*VZLOOEHSHUIRUPHGDVRXWOLQHGLQWKH6WXG\)ORZ&KDUWXVLQJVHQVLWLYH
HOHFWURGHVRURWKHUSUHFDXWLRQDU\ PHDVXUHHQVXULQJWKHVXEMHF WÂ¶VVNLQLVQRWKDUPHGIURPWKH
SURFHGXUHHJ6RI7RXFKÂŒ(OHFWURGHV(&*VZLOOEHSHUIRUPHGRQVXEMHFWVLQVXSLQHSRVLWLRQ
$OO(&*WUDFLQJVZLOOEHUHYLHZHGE\WKH6WXG\3K\VLFLDQRUKLVKHUGHVLJQHH$VXEMHFWZLOOEHZLWKGUDZQIURPWKHVWXG\E\WKH6WXG\3K\VLFLDQRUKLVKHUGHVL JQHHLILQWKHLUPHGLFDO
MXGJPHQW(&*ILQGLQJVDUHSUHVHQ WZKLFKPDNHFRQWLQXHGVWXG\S DUWLFLSDWLRQQRWLQWKH
VXEMHFWÂ¶VEHVWLQWHUHVW
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

7KH(&*FRUUHVSRQGLQJWRWKHILQD OYLVLWRIWKHIHHGHUVWXGLHV ZLOOEHXVHGDVWKH%DVHOLQHGDWD
IRUWKLVVWXG\DQGQHHGQRWEHUHSHDWHG
3UHJQDQF\WHVWV
$WWKHWLPHSRLQWVVSHFLILHGLQ WKH6WXG\)ORZ&KDUWDTXDOLILH GVWDIIPHPEHUZLOOSHUIRUPD
XULQHSUHJQDQF\WHVWIRUVXEMHFW VZKRDUH:2&%37KHXULQHSUHJ QDQF\WHVWNLWVXVHGPXVWKDYH
DPLQLPXPVHQVLWLYLW\RIP,8Â‰+&*P/RIXULQH
6XEMHFWVZKRDUH:2&%3PXVWKDYHD QHJDWLYHSUHJQDQF\WHVWUHVX OWDW%DVHOLQHWREHHQUROOHG
LQWKHVWXG\
,IWKHUHVXOWRIDQ\SRVWVWXG\ PHGLFDWLRQDSSOLFDWLRQXULQHSU HJQDQF\WHVWLVSRVLWLYHWKHVXEMHFW
ZLOOEHZLWKGUDZQIURPWKHVWXG\DQGWKHVXEMHFWÂ¶VSUHJQDQF\ZL OOEHGRFXPHQWHGDQGIROORZHG
XQWLOFRPSOHWLRQDQGIRUDWOHDVWZHHNVDIWHUELUWK
7KHSUHJQDQF\WHVWUHVXOWIURPWKHIHHGHUVWXGLHVILQDOYLVLW DVDSSOLFDEOHZLOOEHXVHGDVWKH
%DVHOLQHGDWDIRUWKLVVWXG\DQGQHHGQRWEHUHSHDWHGXQOHVVWK HYLVLWRFFXUVRXWVLGHWKHZLQGRZ
DOORZHGLQWKH6WXG\)ORZ&KDUW

2WKHU(YDOXDWLRQV
&OLQLFDO$VVHVVPHQW
7KHLQYHVWLJDWRUZLOOGHWHUPLQHLIWKHVXEMHFWKDVDFWLYH(%6O HVLRQVHJ(%6OHVLRQVWKDW
UHTXLUHWUHDWPHQWZLWKWKHVWXG\PHGLFDWLRQDWWKHWLPHSRLQWV VSHFLILHGLQWKH6WXG\)ORZ&KDUW
7KHLQYHVWLJDWRUZLOOEHUHVSRQVLEOHIRUUHFRUGLQJSUHVHQFHRU DEVHQFHRIDFWLYHOHVLRQVDQG
DVVRFLDWHG%6$RIDOODFWLYHOHVLRQVWKDWUHTXLUHWUHDWPHQW 7KHLQYHVWLJDWRUZLOOQRWEH
UHTXLUHGWRDVVHVV OHVLRQVHYHULW\
7RWDO9ROXPHRI%ORRG&ROOHFWHG
7KHWRWDOQXPEHURIYHQLSXQFWXUHVDQGWKHWRWDOYROXPHRIEORRGFROOHFWHGGXULQJWKHVWXG\ZLOO
EHOLPLWHGWRWKDWQHHGHGIRUVDIHW\PRQLWRULQJ7KHWRWDOEORR GYROXPHFROOHFWHGIRUHDFKVXEMHFW
IRUWKHHQWLUHVWXG\ZLOOEHFRPSOLDQWZLWK:+2JXLGHOLQHV'XH WR:+2FRPSOLDQFHVDIHW\
ODERUDWRU\WHVWVZLOOEHSULRULWL]HGLIQRWDOOODERUDWRU\VDPS OHVFDQEHFROOHFWHGGXHWRYROXPH


%DVHOLQH
 (QGRI&\FOH
$GXOWV 1$VDPSOHXVHGIURPIHHGHU
VWXG\PO
&KLOGUHQ\HDUV 1$VDPSOHXVHGIURPIHHGHUVWXG\PO

LIVDPSOHVQHHGWREHUHFROOHFWHGEHFDXVHYLVLWRFFXUVRXWVLG HDOORZDEOHZLQGRZPORIEORRG
ZLOOEHGUDZQIRU%DVHOLQH
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

$'9(56((9(176
$GYHUVHHYHQWVZLOOEHPRQLWRUHG WKURXJKRXWWKHVWXG\DQGLPPHG LDWHO\UHSRUWHGRQWKH
DSSURSULDWH$(&5)

$GYHUVHHYHQWVV
$QDGYHUVHHYHQWLVGHILQHGDVDQ\XQWRZDUGPHGLFDORFFXUUHQFHLQDFOLQLFDOLQYHVWLJDWLRQ
VXEMHFWDGPLQLVWHUHGDSKDUPDFH XWLFDOSURGXFWZKLFKGRHVQRWQ HFHVVDULO\KDYHDFDXVDO
UHODWLRQVKLSZLWKWKLVWUHDWPHQW $QDGYHUVHHYHQWFDQWKHUHIRU HEHDQ\XQIDYRUDEOHDQGRU
XQLQWHQGHGVLJQLQFOXGLQJDQDEQRUPDOODERUDWRU\ILQGLQJV\P SWRPRUGLVHDVHWHPSRUDOO\
DVVRFLDWHGZLWKWKHXVHRIDQL QYHVWLJDWLRQDOPH GLFLQDOSURGXFW ZKHWKHURUQRWUHODWHGWRWKH
LQYHVWLJDWLRQDOPHGL FLQDOSURGXFW$OODGYHUVHHYHQWVLQFOXGLQ JREVHUYHGRUYROXQWHHUHG
SUREOHPVFRPSODLQWVRUV\PSWR PVDUHWREHUHFRUGHGRQWKHDS SURSULDWH&5)
:RUVHQLQJRIDQ\(%6OHVLRQDVVH VVPHQWVKRXOGEHUHSRUWHGDVDQ $(21/<LIWKHXVHRIWKH
VWXG\PHGLFDWLRQLVLQWHUUXSWHGR UGLVFRQWLQXHGRULIWKHUDS\ LVUHTXLUHGWRPDQDJHWKHHYHQW$W
HDFKYLVLWWKH,QYHVWLJDWRUVKRXOGH[DPLQHWKHOHVLRQVEHLQJWU HDWHGIRUDQ\DGYHUVHHYHQWV
VSHFLILFWRWUHDWPHQW(YHQWVV KRXOGEHUHFRUGHGRQWKHDSSURSU LDWHH&5)
$GYHUVHHYHQWVZKLFKLQFOXGHFOLQLFDOODERUDWRU\WHVWYDULDEOH VZLOOEHPRQLWRUHGDQG
GRFXPHQWHGIURPWKHWLPHWKHVXEM HFWVLJQVDQLQIRUPHGFRQVHQW $1'KDVDQ\VWXG\UHODWHG
SURFHGXUHFRQGXFWHGXQWLOWKHVXEMHFWÂ¶VVWXG\SDUWLFLSDWLRQLV FRPSOHWH25XQWLOGD\VDIWHU
WKHVXEMHFWÂ¶VODVWVWXG\PHGLFDWLRQDSSOLFDWLRQZKLFKHYHULVO RQJHU
$GYHUVHHYHQWVWKDWZHUHUHSRUWHGLQWKH&&3 RU&&3 VWXGLHVDQGDUHRQJRLQJ
DW%DVHOLQHIRUWKLVVWXG\PXVWEHUHSRUWHGIRUWKLVVWXG\
6XEMHFWFDUHJLYHUVVKRXOGEHLQVWU XFWHGWRUHSRUWDQ\DGYHUVHH YHQWWKDWWKH\H[SHULHQFHWRWKH
,QYHVWLJDWRU,QYHVWLJDWRUVVKRXOGPDNHDQDVVHVV PHQWIRUDGYHU VHHYHQWVDWHDFKYLVLWDQGUHFRUG
WKHHYHQWRQWKHDSSURSUL DWHDGYHUVHHYHQW&5)
:KHUHYHUSRVVLEOHDVSHFLILFGLVHDVHRUV\QGURPHUDWKHUWKDQL QGLYLGXDODVVRFLDWHGVLJQVDQG
V\PSWRPVVKRXOGEHLGHQWLILHGE\ WKH,QYHVWLJDWRUDQGUHFRUGHG RQWKH&5)+RZHYHULIDQ
REVHUYHGRUUHSRUWHGVLJQRUV\P SWRPLVQRWFRQVLGHUHGDFRPSRQ HQWRIDVSHFLILFGLVHDVHRU
V\QGURPHE\WKH,QYHVWLJDWRULWVKRXOGEHUHFRUGHGDVDVHSDUD WHDGYHUVHHYHQWRQWKH&5)
$GGLWLRQDOO\WKHFRQGLWLRQWKDWO HGWRDPHGLFDORUVXUJLFDOSURFHGXUH HJVXUJHU\HQGRVFRS\
WRRWKH[WUDFWLRQRUWUDQVIXVLRQVKRXOGEHUHFRUGHGDVDQDGYH UVHHYHQWQRWWKHSURFHGXUH
$Q\PHGLFDOFRQGLWLRQDOUHDG\SUHVHQWDW%DVHOLQHWKDWLVQRWUHSRUWHGDVDQRQJRLQJ$(IURP
WKH&&3RU&&3VW XGLHVVKRXOGQRWEHUHSRUWHG DVDQDGYHUVHHYHQWXQOHVVWKH
PHGLFDOFRQGLWLRQRUVLJQVRUV\PS WRPVZRUVHQVLQVHYHULW\RUVHULRXVQHVVDWDQ\WLPHGXULQJWKH
VWXG\,QWKLVFDVHLWVKRXOGEHUHSRUWHGDVDQDGYHUVHHYHQW 
&OLQLFDOO\VLJQLILFDQWDEQRUPDOODERUDWRU\RURWKHUH[DPLQDWLRQ HJHOHFWURFDUGLRJUDP
ILQGLQJVWKDWDUHGHWHFWHGGXULQJWKHVWXG\DUHUHSRUWHGDVRQ JRLQJ$(VIURPWKH&&3
RU&&3VWXGLHVDW%DVHOLQH VKRXOGEHUHSRUWHGDVDGYHUV HHYHQWV7KH,QYHVWLJDWRUZLOO
H[HUFLVHKLVRUKHUPHGLFDODQGVFLHQWLILFMXGJPHQWLQGHFLGLQJ ZKHWKHUDQDEQRUPDOODERUDWRU\
ILQGLQJRURWKHUDEQRUPDODVVHVVPHQWLV&5&5DEQRUPDOODERUDW RU\YDOXHVRFFXUULQJGXULQJWKH
FOLQLFDOVWXG\ZLOOEHIROORZHGXQWLOUHSHDWWHVWVUHWXUQWRQRUPDOVWDELOL]HRUDUHQRORQJHU&5
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

$Q\DEQRUPDOWHVWWKDWLVGHWHU PLQHGWREHDQHUURUGRHVQRWUHTXLUHUHSRUWLQJDVDQDGYHUVH
HYHQW

$GYHUVH'UXJ5HDFWLRQ
$OOQR[LRXVDQGXQLQWHQGHGUHVSRQV HVWRDPHGLFLQDOSURGXFWUHO DWHGWRDQ\GRVHVKRXOGEH
FRQVLGHUHGDQDGYHUVHGUXJUHDF WLRQÂ³5HVSRQVHVÂ´WRDPHGLFLQDOSURGXFWPHDQVWKDWDFDXVDO
UHODWLRQVKLSEHWZHHQDPHGLFLQDO SURGXFWDQGDQDGYHUVHHYHQWL VDWOHDVWDUHDVRQDEOHSRVVLELOLW\
LHWKHUHODWLRQVKLSFDQQRWEHUXOHGRXW

8QH[SHFWHG$GYHUVH'UXJ5HDFWLRQ
$Q8QH[SHFWHG$GYHUVH'UXJ5HDFWLRQLVGHILQHGDVDQDGYHUVHUH DFWLRQWKHQDWXUHRUVHYHULW\
RIZKLFKLVQRWFRQVLVWHQWZLWKWKHDSSOLFDEOHSURGXFWLQIRUPDW LRQ

$VVHVVPHQWVRI$GYHUVH(YHQWVE\WKH,QYHVWLJDWRU
7KH,QYHVWLJDWRUZLOODVVHVVWKHVHYHULW\LQWHQVLW\RIHDFKDGYHUVHHYHQWDVPLOGPRGHUDWHRU
VHYHUHDQGZLOODOVRFDWHJRUL]HHDFKDGYHUVHHYHQWDVWRLWVS RWHQWLDOUHODWLRQVKLSWRVWXG\GUXJ
XVLQJWKHFDWHJRULHVRI\HVRUQR
$VVHVVPHQWRI6HYHULW\
0LOGÂ±$QHYHQWWKDWLVHDVLO\WROHUDWHGDQGJHQHUDOO\QRWLQWHUIHULQJZLWKQRUPDOGDLO\DFWLYLWLHV
0RGHUDWHÂ±$QHYHQWWKDWLVVXIILFLHQWO\GLVFRPI[INVESTIGATOR_226893]WRLQWHU IHUHZLWKQRUPDOGDLO\DFWLYLWLHV
6HYHUHÂ±$QHYHQWWKDWLVLQFDSDFLWDWLQJZLWKLQDELOLW\WRZRUN RUSHUIRUPQRUPDOGDLO\DFWLYLWLHV
&DXVDOLW\$VVHVVPHQW
7KHUHODWLRQVKLSRIDQDGYHUVHHYHQWWRWKHDGPLQLVWUDWLRQRIW KHVWXG\GUXJLVWREHDVVHVVHG
DFFRUGLQJWRWKHIROORZLQJGHILQLWLRQV

$VVRFLDWLRQ 'HILQLWLRQ
1RWUHODWHG WKHH[ LVWHQFHRIDFOHDUD OWHUQDWLYHH[SODQDWLR QHJPHFKDQLFDOEOHHGLQJDWVXUJLFDO
VLWHRUQRQSODXVLELOLW\HJWKHVXEMHFWLVVWUXFNE\DQDXWRPRELOHRUFDQFHU
GHYHORSLQJDIHZGD\VDIWHUGUXJDGPLQLVWUDWLRQ
8QOLNHO\ 7KHUHLVQRPHGLFDOHYLGHQFHWRVXJJHVWWKDWWKH$(PD \EHUHODWHGWRVWXG\GUXJXVDJH
RUWKHUHLVDQRWKHUPRUHSUREDEOHPHGLFDOH[SODQDWLRQ
3RVVLEOH 7KHUHLVPHGLFDOHYLGHQFHWRVXJJHVWWKDWWKHUHLVDU HDVRQDEOHSRVVLELOLW\WKDWWKH$(PD\
EHUHODWHGWRVWXG\GUXJXVDJH +RZHYHURWKHUPHGLFDOH[SODQDW LRQVFDQQRWEHH[FOXGHG
DVDSRVVLEOHFDXVH
3UREDEOH 7KHUHLVVWURQJPHGLFDOHYLGHQFHWRVXJJHVWWKDWWKH$ (LVUHODWHGWRVWXG\GUXJXVDJH
'HILQLWH $FOLQLFDOHYHQWLQFOXGLQJODERUDWRU\WHVWDEQRUPDOLW \LIDSSOLFDEOHLQZKLFKWKHUHLVQR
XQFHUWDLQW\LQLWVUHODWLRQVKLSWRWHVWGUXJHJSRVLWLYH5H FKDOOHQJH 
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

7KHIROORZLQJIDFWRUVVKRXOGDOVREHFRQVLGHUHG
x7KHWHPSRUDOVHTXHQFHIURPVWXG\GUXJDGPLQLVWUDWLRQ
7KHHYHQWVKRXOGRFFXUDIWHUWKHVWXG\GUXJLVJLYHQ7KHOHQJW KRIWLPHIURP
VWXG\GUXJH[SRVXUHWRHYHQWVKRXOGEHHYDOXDWHGLQWKHFOLQLFDOFRQWH[WRIWKH
HYHQW
x8QGHUO\LQJFRQFRPLWDQWL QWHUFXUUHQWGLVHDVHV
(DFKUHSRUWVKRXOGEHHYDOXDWHGLQWKHFRQWH[WRIWKHQDWXUDOKLVWRU\DQGFRXUVHRI
WKHGLVHDVHEHLQJWUHDWHGDQGDQ\RWKHUGLVHDVHWKHVXEMHFWPD\ KDYH
x&RQFRPLWDQWGUXJ
7KHRWKHUGUXJVWKHVXEMHFWLVWDNLQJRUWKHWUHDWPHQWWKHVXEM HFWUHFHLYHVVKRXOG
EHH[DPLQHGWRGHWHUPLQHZKHWKHU DQ\RIWKHPPLJKWEHUHFRJQL]H GWRFDXVHWKH
HYHQWLQTXHVWLRQ
x.QRZQUHVSRQVHSDWWHUQIRUWKLVFODVVRIVWXG\GUXJ
&OLQLFDODQGRUSUHFOLQLFDOGDWDPD\LQGLFDWHZKHWKHUDSDUWLFX ODUUHVSRQVHLV
OLNHO\WREHDFODVVHIIHFW
x([SRVXUHWRSK\VLFDODQGRUPHQWDOVWUHVVHV
7KHH[SRVXUHWRVWUHVVPLJKWLQGXFHDGYHUVHFKDQJHVLQWKHUHFL SLHQWDQGSURYLGH
DORJLFDODQGEHWWHUH[SODQDWLRQIRUWKHHYHQW
x7KHSKDUPDFRORJ\DQGSKDUPDFRNLQHWLFVRIWKHVWXG\GUXJ7KHNQRZQSKDUPDFRORJLFSURSHUWLH VDEVRUSWLRQGLVWULEXWLRQP HWDEROLVPDQG
H[FUHWLRQRIWKHVWXG\GUXJVKRXOGEHFRQVLGHUHG

$GYHUVH(YHQWVRI6SHFLDO,QWHUHVW
$QDGYHUVHHYHQWRIVSHFLDOLQWHUHVWVHULRXVRUQRQVHULRXVLVRQHRIVFLHQWLILFDQGPHGLFDO
FRQFHUQVSHFLILFWRWKHSURJUDP IRUZKLFKRQJRLQJPRQLWRULQJD QGUDSLGFRPPXQLFDWLRQE\WKH
LQYHVWLJDWRUWRWKHVSRQVRUPD\E HDSSURSULDWH6XVSLFLRQRIVX FKDQHYHQWPLJKWZDUUDQWIXUWKHU
LQYHVWLJDWLRQLQRUGHUWRFKDU DFWHUL]HDQGXQGHUVWDQGLW&HUWD LQ$(VZLOOEHFDWHJRUL]HGDV$(V
RIVSHFLDOLQWHUHVW$(6,VLQWKLVVWXG\ZLOOLQFOXGHWKHIROORZLQJ
x0RGHUDWHWRVHYHUHGLDU[LOCATION_006]HD
x+HSDWLFLQMXU\
x3DQFUHDWLWLV
x8UWLFDULDDQJLRHGHPD
x(SLGHUPDOQHFURO\VLV
x'UXJUHDFWLRQZLWKHRVLQRSKLOLDDQGV\VWHPLFV\PSWRPV'5(66
x3XUSXUDFXWDQHRXVYDVFXOLWLV
x-DXQGLFH
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

$OO$(6,VZLOOEHVX[COMPANY_003]UL]HGDVQ DUUDWLYHVLQWKH&OLQLFDO6WXG \5HSRUW

6HULRXV$GYHUVHHYHQWV6$(
$QDGYHUVHHYHQWRUDGYHUVHUHDF WLRQLVFRQVLGHUHGVHULRXVLI LQWKHYLHZRIHLWKHUWKH
,QYHVWLJDWRURU6SRQVRULWUHVXOWVLQDQ\RIWKHIROORZLQJRXWFRPHV
x'HDWK
x$OLIHWKUHDWHQLQJDGYHUVHHYHQW
127($QDGYHUVHHYHQWRUDGYHUV HUHDFWLRQLVFRQVLGHUHGÂ³OLIH WKUHDWHQLQJÂ´LILQ
YLHZRIHLWKHUWKH,QYHVWLJDWRU RU6SRQVRULWVRFFXUUHQFHSODF HVWKHVXEMHFWDW
LPPHGLDWHULVNRIGHDWK,WGRH VQRWLQFOXGHDQHYHQWWKDWKDGLWRFFXUUHGLQD
PRUHVHYHUHIRUPPLJKWKDYHFDXVHGGHDWK
x5HTXLUHVKRVSLWDOL]DWLRQRUSUR ORQJDWLRQRIH[LVWLQJKRVSLWDOL] DWLRQV
127($Q\KRVSLWDODGPLVVLRQZLWKDWOHDVWRQHRYHUQLJKWVWD\ZLOOEHFRQVLGHUHG
DQLQSDWLHQWKRVSLWDOL]DWLRQ$QHPHUJHQF\URRPYLVLWZLWKRXWK RVSLWDODGPLVVLRQ
ZLOOQRWEHUHFRUGHGDVD6$( XQGHUWKLVFULWHULRQQRUZLOOKR VSLWDOL]DWLRQIRUD
SURFHGXUHVFKHGXOHGRUSODQQHGEH IRUHVLJQLQJRILQIRUPHGFRQVH QW+RZHYHU
XQH[SHFWHGFRPSOLFDWLRQVDQGRUS URORQJDWLRQRIKRVSLWDOL]DWLRQ WKDWRFFXUGXULQJ
HOHFWLYHVXUJHU\VKRXOGEHUHFRUG HGDVDGYHUVHHYHQWVDQGDVVHV VHGIRU
VHULRXVQHVV$GPLVVLRQWRWKHKRV SLWDOIRUVRFLDORUVLWXDWLRQD OUHDVRQV LHQR
SODFHWRVWD\OLYHWRRIDUDZD\WRFRPHIRUKRVSLWDOYLVLWVZ LOOQRWEHFRQVLGHUHG
LQSDWLHQWKRVSLWDOL]DWLRQV
x$SHUVLVWHQWRUVLJQLILFDQWGLVDELOLW\LQFDSDFLW\RUVXEVWDQWLD OGLVUXSWLRQRIWKHDELOLW\
WRFRQGXFWQRUPDOOLIHIXQFWLRQV
x$FRQJHQLWDODQRPDO\ELUWKGHIHFWRU
x$QLPSRUWDQWPHGLFDOHYHQW
127(,PSRUWDQWPHGLFDOHYHQWVWK DWPD\QRWUHVXOWLQGHDWKEH OLIHWKUHDWHQLQJ
RUUHTXLUHKRVSLWDOL]DWLRQPD\EHFRQVLGHUHGDQ6$(ZKHQEDVHG XSRQ
DSSURSULDWHPHGLFDOMXGJPHQWWKH \PD\MHRSDUGL]HWKHVXEMHFWD QGPD\UHTXLUH
PHGLFDORUVXUJLFDOLQWHUYHQWLRQ WRSUHYHQWRQHRIWKHRXWFRPHV OLVWHGDERYH
([DPSOHVRIVXFKPHGLFDOHYHQWVLQFOXGHDOOHUJLFEURQFKRVSDVPU HTXLULQJ
LQWHQVLYHWUHDWPHQWLQDQHPHUJHQF\URRPRUDWKRPHEORRGG\VF UDVLDVRU
FRQYXOVLRQVWKDWGRQRWUHVXOWLQLQSDWLHQWKRVSLWDOL]DWLRQVR UWKHGHYHORSPHQWRI
GUXJGHSHQGHQF\

6HULRXV$GYHUVH(YHQW$GYHUVH (YHQWVRI6SHFLDO,QWHUHVW5HSRUWLQJÂ±
3URFHGXUHVIRU,QYHVWLJDWRUV

,QLWLDO5HSRUWV
$OO6$(V$(6,UHJDUGOHVVRIFDXVDOLW\RFFXUULQJIURPWKHWLPHRILQIRUPHGFRQVHQWXQWLO
FRPSOHWLRQRIWKHVXEMHFWÂ¶VODVWVWXG\YLVLW25XQWLOGD\VD IWHUWKHVXEMHFWÂ¶VODVWDSSOLFDWLRQRI
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

VWXG\PHGLFDWLRQZKLFKHYHULVORQJHUPXVWEHUHSRUWHGWR&52&OLQLFDO6DIHW\ZLWKLQKRXUV
RIWKHNQRZOHGJHRIWKHRFFXUUHQFHWKLVUHIHUVWRDQ\DGYHUVH HYHQWWKDWPHHWVDQ\RIWKH
DIRUHPHQWLRQHGVHULRXVFULWHULD 6$(V$(6,RFFXUULQJDIWHUWKH GD\IROORZXSSHULRG$1'
FRQVLGHUHGUHODWHGWRVWXG\GUXJ PXVWDOVREHUHSRUWHGWRWKH6 SRQVRU
6$(V$(6,WKDWZHUHUHSRUWHGIURPWKHIHHGHUVWXGLHVDQGDUHRQ JRLQJDW%DVHOLQHIRUWKLVVWXG\
PXVWEHUHSRUWHGIRUWKLVVWXG\
7RUHSRUWDQ6$($(6,FRPSOHWHWKH6$($(6,IRUPHOHFWURQLFDOO \LQWKHHOHFWURQLFGDWD
FDSWXUH('&V\VWHPIRUWKHVWX G\:KHQWKHIRUPLVFRPSOHWHG 0HGSDFH6DIHW\SHUVRQQHOZLOO
EHQRWLILHGHOHFWURQLFDOO\,IWKHHYHQWPHHWVVHULRXVFULWHULD DQGLWLVQRWSRVVLEOHWRDFFHVVWKH
('&V\VWHPVHQGDQHPDLOWR0HGSDFH6DIHW\DW0HGSDFHVDIHW\QRWLILFDWLRQ#0HGSDFHFRPRU
FDOOWKH0HGSDFH6$($(6,KRWOLQHSKRQHQXPEHUOLVWHGEHORZDQGID[WKHFRPSOHWHGSDSHU6$($(6,IRUPWR0HGSDFHID[QXPEHUOLVWHGEHORZZLWKLQKRXUVRIDZDUHQHVV:KHQWKH
('&V\VWHPEHFRPHVDYDLODEOHWKH6$($(6,LQIRUPDWLRQPXVWEH HQWHUHGZLWKLQKRXUVRI
WKHV\VWHPEHFRPLQJDYDLODEOH

6DIHW\&RQWDFW,QIRUPDWLRQ0HGSDFH&OLQLFDO6DIHW\0HGSDFH6$(KRWOLQHÂ±86$7HOHSKRQH)D[HPDLO

)ROORZXS5HSRUWV
7KH,QYHVWLJDWRUPXVWFRQWLQXHWRIROORZWKHVXEMHFWXQWLOWKH6$($(6,KDVVXEVLGHGRUXQWLO
WKHFRQGLWLRQEHFRPHVFKURQLFLQQDWXUHVWDELOL]HVLQWKHFDV HRISHUVLVWHQWLPSDLUPHQWRUWKH
VXEMHFWGLHV
:LWKLQKRXUVRIUHFHLSWRIIROORZXSLQIRUPDWLRQWKH,QYHVW LJDWRUPXVWXSGDWHWKH6$($(6,
IRUPHOHFWURQLFDOO\LQWKH('&V\VWHPIRUWKHVWXG\DQGVXEPLW DQ\VXSSRUWLQJGRFXPHQWDWLRQ
HJVXEMHFWGLVFKDUJHVX[COMPANY_003]U\DX WRSV\UHSRUWVHWFWR&52&OLQ LFDO6DIHW\YLDID[RUHPDLO
,ILWLVQRWSRVVLEOHWRDFFHVVWKH('&V\VWHPUHIHUWRWKHSU RFHGXUHVRXWOLQHGDERYHIRULQLWLDO
UHSRUWLQJRI6$(V$(6,
([SHGLWHG5HSRUWV
7KH6SRQVRUZLOOUHSRUWDOOUHOHYDQWLQIRUPDWLRQDERXWVXVSHFWH GXQH[SHFWHGVHULRXVDGYHUVH
UHDFWLRQVWKDWDUHIDWDORUOLI HWKUHDWHQLQJDVVRRQDVSRVVLEO HWRWKH)'$DSSOLF DEOHFRPSHWHQW
DXWKRULWLHVLQDOOWKH0HPEHU6WDWHVFRQFHUQHGDQGWRWKH&HQWUDO(WKLFV&RPPLWWHHDQGLQDQ\
FDVHQRODWHUWKDQGD\VDIWHUNQRZOHGJHE\WKH6SRQVRURIVX FKDFDVHDQGWKDWUHOHYDQW
IROORZXSLQIRUPDWLRQZLOOVXEVH TXHQWO\EHFRPPXQLFDWHGZLWKLQ DQDGGLWLRQDOGD\V
$OORWKHUVXVSHFWHGXQH[SHFWHGV HULRXVDGYHUVHUHDFWLRQV$(6,Z LOOEHUHSRUWHGWRWKH)'$
DSSOLFDEOHFRPSHWHQWDXWKRULWLHVFRQFHUQHGDQGWRWKH&HQWUDO( WKLFV&RPPLWWHHFRQFHUQHGDV
VRRQDVSRVVLEOHEXWZLWKLQDPD[LPXPRIGD\VRIILUVWNQRZO HGJHE\WKH6SRQVRU
7KH6SRQVRUZLOODOVRLQIRUPDOOLQYHVWLJDWRUVDVUHTXLUHG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

35(*1$1&<5(3257,1*
:2&%3LQFOXGHDQ\IHPDOHZKRKDV H[SHULHQFHGPHQDUFKHDQGZKRK DVQRWXQGHUJRQH
VXFFHVVIXOVXUJLFDOVWHULOL]DWLRQ HJK\VWHUHFWRP\ELODWHUDOWXEDOOLJDWLRQELODWHUDO
RRSKRUHFWRP\RULVQRWSRVWPHQRSDXVDO3RVWPHQRSDXVDOLVGHILQ HGDVÂ•PRQWKVZLWKQR
PHQVHVZLWKRXWDQDOWHUQDWLYHPH GLFDOFDXVH:RPHQZKRDUH:2&% 3DQGDUHXVLQJDQDFWLYH
PHWKRGRIELUWKFRQWURODUHSU DFWLFLQJDEVWLQHQFHRUZKHUHWKH SDUWQHULVVWHULOH HJ
YDVHFWRP\VKRXOGEHFRQVLGHUHGWREH:2&%3
$OO:2&%3PXVWXVHDQHIIHFWLYH DFWLYHPHWKRGRIELUWKFRQWURO IRUWKHGXUDWLRQRIVWXG\
SDUWLFLSDWLRQLQDPDQQHUVXFKWKDWULVNRIIDLOXUHLVPLQLPL]H G3HULRGLFDQGRUWHPSRUDU\
DEVWLQHQFHVXFKDVGHFODUDWLRQ RIDEVWLQHQFHGXULQJVWXG\SDUWLFLSDWLRQRUIHUWLOLW\DZDUHQHVV
EDVHGPHWKRGVWRSUHYHQWSUHJQDQF \LQFOXGLQJEXWQRWOLPLWHGWRV\PSWRWKHUPDODQGRYXODWLRQ
HVWLPDWLRQE\HLWKHUFDOHQGDUGD\RUVDOLYDU\FHUYLFDOVHFUHWLRQVDUHQRWFRQVLGHUHGHIIHFWLYH
PHWKRGVRIELUWKFRQWUROKRZHYHU WUXH>DEVROXWH@VH[XDODEVWL QHQFHLHLQOLQHZLWKWKH
SUHIHUUHGDQGXVXDOOLIHVW\OHRIWKHSDWLHQWPD\EHSHUPLWWHG (IIHFWLYHPHWKRGVRIELUWKFRQWURO
DSSURYHGIRUXVHLQWKLVVWXG\DUH
x,PSODQWVHJ1RUSODQWÂŠV\VWHP
x,QMHFWDEOHHJ'HSR3URYHUDÂŠ
x7UDQVGHUPDOSDWFK
x&RPELQHGRUDOFRQWUDFHSWLYHV
x%DUULHUPHWKRGVFRQGRPVDQGGLDSKUDJPZLWKVSHUPLFLGHÂ±QRWH GRXEOHEDUULHU
PHWKRGLVUHTXLUHGLIQRRWKHUPH WKRGVRIELUWKFRQWURODUHLQ XVH
x,QWUDXWHULQHGHYLFHVHJ3DUD*DUGÂŠDQG0LUHQDÂŠ
3ULRUWRWULDOHQUROOPHQW:2&%3 PXVWEHDGYLVHG RIWKHLPSRUWD QFHRIDYRLGLQJSUHJQDQF\
GXULQJWULDOSDUWLFLSDWLRQDQGWKHSRWHQWLDOULVNIDFWRUVIRUD SUHJQDQF\7KHVXEMHFWFDUHJLYHU
PXVWVLJQDQLQIRUPHGFRQVHQWD VVHQWIRUPGRFXPHQWLQJWKLVGLVF XVVLRQ'XULQJWKHWULDODOO
:2&%3ZLOOEHLQVWUXFWHGWRFRQWDFWWKHLQYHVWLJDWRULPPHGLDWHO\LIWKH\VXVSHFWWKH\PLJKWEH
SUHJQDQW HJPLVVHGRUODWHPHQVWUXDOSHULRG
$OOSUHJQDQFLHVRFFXUULQJIURPW KHWLPHRILQIRUPHGFRQVHQWXQW LOFRPSOHWLRQRIWKHVXEMHFWÂ¶V
ODVWVWXG\YLVLW25XQWLOGD\VDIWHUWKHVXEMHFWÂ¶VODVWDSSO LFDWLRQRIVWXG\PHGLFDWLRQ
ZKLFKHYHULVORQJHUPXVWEHUHSRUWHGWR&52&OLQLFDO6DIHW\ZL WKLQKRXUVRINQRZOHGJHRI
WKHSUHJQDQF\&52&OLQLFDO6DIHW\ZLOOWKHQIRUZDUGWKH([SRVX UHLQXWHURIRUPWRWKH
,QYHVWLJDWRUIRUFRPSOHWLRQ
,IDVXEMHFWFDUHJLYHURULQYHV WLJDWRUVXVSHFWVWKDWWKHVXEMHF WPD\EHSUHJQDQWSULRUWRVWXG\
PHGLFDWLRQDGPLQLVWUDWLRQWKHVWX G\PHGLFDWLRQPXVWEHZLWKKHO GXQWLOWKHUHVXOWVRID
SUHJQDQF\WHVWDUHDYDLODEOH,I SUHJQDQF\LVFRQILUPHGWKHVX EMHFWPXVWQRWUHFHLYHVWXG\
PHGLFDWLRQDQGPXVWEHWHUPLQDWHGIURPWKHVWXG\
,IIROORZLQJVWXG\PHGLFDWLRQDGPLQLVWUDWLRQLWLVGHWHUPLQHG WKDWWKHVXEMHFWPD\KDYHEHHQRU
ZDVSUHJQDQWDWWKHWLPHRIVWXG\PHGLFDWLRQH[SRVXUHLQFOXGLQ JDWOHDVWGD\VDIWHUVWXG\
PHGLFDWLRQDGPLQLVWUDWLRQWKHVXEMHFWZLOOLPPHGLDWHO\EHZLW KGUDZQIURPWKHVWXG\DQGHDUO\
WHUPLQDWLRQVWXG\SURFHGXUHVZLOOEHSHUIRUPHGXQOHVVFRQWUDLQG LFDWHGE\SUHJQDQF\7KH
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

LQYHVWLJDWRUPXVWLPPHGLDWHO\ZLWKLQKRXUVQRWLI\WKH&DVW OH&UHHN3KDUPDFHXWLFDOV//&
0HGLFDO0RQLWRU
3URWRFROUHTXLUHGSURFHGXUHVIRU WULDOGLVFRQWLQXDWLRQDQGIROO RZXSPXVWEHSHUIRUPHGRQWKH
VXEMHFWXQOHVVFRQWUDLQGLFDWHGE\SUHJQDQF\2WKHUDSSURSULDWH SUHJQDQF\IROORZXSSURFHGXUHV
VKRXOGEHFRQVLGHUHGLILQGLFDWHG7KHVXEMHFWÂ¶VSUHJQDQF\VKRXOGEH IROORZHGE\WKH,QYHVWLJDWRUXQWLOFRPSOHWLRQDQGIRUDWOHDVW
ZHHNVDIWHUELUWK,IWKHSUHJQDQF\HQGVIRUDQ\UHDVRQEHIRU HWKHDQWLFLSDWHGGDWHWKH
,QYHVWLJDWRUVKRXOGQRWLI\&52&OLQLFDO6DIHW\$WWKHFRPSOHWL RQRIWKHSUHJQDQF\WKH
,QYHVWLJDWRUZLOOGRFXPHQWWKHRXWFRPHRIWKHSUHJQDQF\,IWKH RXWFRPHRIWKHSUHJQDQF\PHHWV
WKHFULWHULDIRULPPHGLDWHFODVVLILFDWLRQDVDQ6$( LHSRVWSDUWXPFRPSOLFDWLRQVSRQWDQHRXV
DERUWLRQVWLOOELUWKQHRQDWDOGHDWKRUFRQJHQLWDODQRPDO\W KH,QYHVWLJDWRUVKRXOGIROORZWKH
SURFHGXUHVIRUUHSRUWLQJDQ6$(
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

67$7,67,&$/$1$/<6(6
$QDO\VLV3RSXODWLRQV
7KH6DIHW\3RSXODWLRQZLOOFRQVLVWRIDOOVXEMHFWVZKRUHFHLYH DWOHDVWRQHDSSOLFDWLRQRIVWXG\
PHGLFDWLRQ

'DWD$QDO\VLV
0LVVLQJ'DWD+DQGOLQJ0HWKRGV
2QO\WKHREVHUYHGGDWDZLOOEHVX[COMPANY_003]UL]HGIRUHIILFDF\DQGVDIH W\RIWKHVWXG\1RPLVVLQJGDWD
ZLOOEHLPSXWHG

6XEMHFW,QIRUPDWLRQ
$GHWDLOHGGHVFULSWLRQRIVXEMHFWGLVSRVLWLRQZLOOEHSURYLGHG 'HVFULSWLYHVX[COMPANY_003]ULHVRI
GHPRJUDSKLFDQGEDVHOLQHFKDUDFWHULVWLFVZLOOEHSUHVHQWHGIRU WKH6DIHW\3RSXODWLRQ

$QDO\VLVRI6DIHW\
6DIHW\PHDVXUHVZLOOLQFOXGHWKHIROORZLQJDVVHVVPHQWV
x'HPRJUDSKLFV0HGLFDO+LVWRU\
x$GYHUVHHYHQWVDQG6$(V
x9LWDO6LJQV
x&OLQLFDOH[DPLQDWLRQ
x/DERUDWRU\WHVWLQJ
x(&*V
x8ULQHSUHJQDQF\WHVWV
$GYHUVHHYHQWVDQGPHGLFDOKLVWRULHVZLOOEHFRGHGXVLQJWKHPR VWFXUUHQWYHUVLRQRIWKH0HGLFDO
'LFWLRQDU\IRU5HJXODWRU\$FWLYLWLHV0HG'5$1HZRUZRUVHQLQJ DGYHUVHHYHQWVDIWHUGRVLQJ
RIVWXG\GUXJZLOOEHVX[COMPANY_003]UL]HGE\V\VWHPRUJDQFODVVSUHIHUU HGWHUPDQGWUHDWPHQW/LVWVRI
VXEMHFWVZKRKDYHDQ6$($(6,RU ZKRGLVFRQWLQXHIURPWKHVWXG\ GXHWRDQDGYHUVHHYHQWZLOO
EHSURYLGHG
6X[COMPANY_003]U\VWDWLVWLFVIRUODERUDWRU\YDOXHVZLOOEHSURYLGHGDWED VHOLQHSRVWEDVHOLQHYLVLWVDQGIRU
FKDQJHVIURPEDVHOLQHWRSRVWEDVHOLQHE\WUHDWPHQW9LWDOVLJQ VDQG(&*SDUDPHWHUVZLOOEH
VX[COMPANY_003]UL]HGVLPLODUO\2FFXUUHQFHRIVLJQLILFDQWODERUDWRU\DEQR UPDOLWLHVZLOOEHVX[COMPANY_003]UL]HGE\
WUHDWPHQW&OLQLFDOH[DPLQDWLRQD QGRWKHUVDIHW\PHDVXUHPHQWVZLOOEHVX[COMPANY_003]UL]HGDQGOLVWHG

,QWHULP$QDO\VLV
1RLQWHULPDQDO\VLVLVSODQQHG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

6DPSOH6L]H&DOFXODWLRQ
1RIRUPDOVDPSOHVL]HFDOFXODWL RQZDVSHUIRUPHGIRUWKLVH[WHQV LRQVWXG\
$SSUR[LPDWHO\VXEMHFWVDUHDQ WLFLSDWHGWREHHQUROOHGLQWKL VVWXG\DWDSSUR[LPDWHO\
LQWHUQDWLRQDOLQYHVWLJDWLRQDOFHQWHUV7KHDFWXDOQXPEHURIVXE MHFWVWKDWDUHHQUROOHGZLOOGHSHQG
RQWKHILQDOQXPEHURIVXEMHFWV ZKRSDUWLFLSDWHLQWKH&&3RUSDUWLFLSDWHLQWKH&&3
VWXG\
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

',5(&7$&&(66726285&('$7$'2&80(176
6WXG\0RQLWRULQJ
%HIRUHDQLQYHVWLJDWLRQDOVLWHFDQHQWHUDSDWLHQWLQWRWKHVWX G\DUHSUHVHQWDWLYHRI&DVWOH&UHHN
3KDUPDFHXWLFDOV//&ZLOOYLVLWWKHLQYHVWLJDWLRQDOVWXG\VLWH WR
x'HWHUPLQHWKHDGHTXDF\RIWKHIDFLOLWLHV
x'LVFXVVZLWKWKHLQYHVWLJDWRUVDQGRWKHUSHUVRQQHOWKHLUUHVS RQVLELOLWLHVZLWKUHJDUG
WRSURWRFRODGKHUHQFHDQGWKHUHVSRQVLELOLWLHVRI&DVWOH&UHHN 3KDUPDFHXWLFDOV//&
RULWVUHSUHVHQWDWLYHV7KLVZLOOEHGRFXPHQWHGLQD&OLQLFDO6 WXG\$JUHHPHQW
EHWZHHQ&DVWOH&UHHN3KDUPDFHXWLFDOV//&DQGWKHLQYHVWLJDWRU 
'XULQJWKHVWXG\DPRQLWRUIURP&DVWOH&UHHN3KDUPDFHXWLFDOV //&RUUHSUHVHQWDWLYHZLOOKDYH
UHJXODUFRQWDFWVZLWKWKHLQYHVWLJDWLRQDOVLWHIRUWKHIROORZL QJ
x3URYLGHLQIRUPDWLRQDQGVXSSRUWWRWKHLQYHVWLJDWRUV
x&RQILUPWKDWIDFLOLWLHV UHPDLQDFFHSWDEOH
x&RQILUPWKDWWKHLQYHV WLJDWLRQDOWHDPLVDGKHULQJWRWKHSURWRFROWKDWGDWDLVEHLQJ
DFFXUDWHO\UHFRUGHGLQWKHFDVHUHSRUWIRUPVDQGWKDWLQYHVWLJ DWLRQDOSURGXFW
DFFRXQWDELOLW\FKHFNVDUHEHLQJSHUIRUPHG
x3HUIRUPVRXUFHGDWDYHULILFDWLRQ7KLVLQFOXGHVDFRPSDULVRQRI WKHGDWDLQWKHFDVH
UHSRUWIRUPVZLWKWKHSDWLHQWÂ¶VPHGLFDOUHFRUGVDWWKHKRVSLWDO RUSUDFWLFHDQGRWKHU
UHFRUGVUHOHYDQWWRWKHVWXG\7KLVZLOOUHTXLUHDFFHVVWRDOO UHFRUGVIRUHDFKSDWLHQW
HJFOLQLFFKDUWV
x5HFRUGDQGUHSRUWDQ\SURWRFROGH YLDWLRQVQRWSUHYLRXVO\VHQWW R&DVWOH&UHHN
3KDUPDFHXWLFDOV//&
x&RQILUP$(VDQG6$(V$(6,KDYHEHHQSURSHUO\GRFXPHQWHGRQ&5)V DQGFRQILUP
DQ\6$(V$(6,KDYHEHHQIRUZDUGHGWR&DVWOH&UHHN3KDUPDFHXWLFD OV//&DQG
WKHLUUHSUHVHQWDWLYHVDQGFRQILUPWKRVH6$(V$(6,WKDWPHWFULWHULDIRUUHSRUWLQJ
KDYHEHHQIRUZDUGHGWRWKH ,5%(&DVDSSOLFDEOH
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

(7+,&6
(WKLFV5HYLHZ
7KHILQDOVWXG\SURWRFROLQFOXGL QJWKHILQDOYHUVLRQRIWKH,QIRUPHG&RQVHQW)RUPPXVWEH
DSSURYHGRUJLYHQDIDYRUDEOHRSLQLRQLQZULWLQJE\DQ,5%RU, (&DVDSSURSULDWH7KH
LQYHVWLJDWRUPXVWVXEPLWZULWWHQDSSURYDOWR&DVWOH&UHHN3KDUP DFHXWLFDOV//&EHIRUHKHRUVKH
FDQHQUROODQ\SDWLHQWVXEMHFWLQWRWKHVWXG\
7KH3ULQFLSDO,QYHVWLJDWRULVUH VSRQVLEOHIRULQIRUPLQJWKH,5% RU,(&RIDQ\DPHQGPHQWWRWKH
SURWRFROLQDFFRUGDQFHZLWKORFDO UHTXLUHPHQWV,QDGGLWLRQWK H,5%RU,(&PXVWDSSURYHDOO
DGYHUWLVLQJXVHGWRUHFUXLWVXEMHFWVIRUWKHVWXG\7KHSURWRFR OPXVWEHUHDSSURYHGE\WKH,5%
RU,(&XSRQUHFHLSWRIDPHQGPHQWVDQGDQQXDOO\DVORFDOUHJXOD WLRQVUHTXLUH
7KH3ULQFLSDO,QYHVWLJDWRULVDO VRUHVSRQVLEOHIRUSURYLGLQJWKH,5%ZLWKUHSRUWVRIDQ\
UHSRUWDEOHVHULRXVDGYHUVHGUXJU HDFWLRQVIURPDQ\RWKHUVWXG\ FRQGXFWHGZLWKWKH LQYHVWLJDWLRQDO
SURGXFW&DVWOH&UHHN3 KDUPDFHXWLFDOV//&ZLOOSURYLGHWKLVLQIRUPDWLRQWRWKH3ULQFLSDO
,QYHVWLJDWRU
3URJUHVVUHSRUWVDQGQRWLILFDWLRQV RIVHULRXVDGYHUVHGUXJUHDF WLRQVZLOOEHSURYLGHGWRWKH,5%
RU,(&DFFRUGLQJWRORFDOU HJXODWLRQVDQGJXLGHOLQHV

(WKLFDO&RQGXFWRIWKH6WXG\
7KHVWXG\ZLOOEHSHUIRUPHGLQ DFFRUGDQFHZLWKHWKLFDOSULQFLSOHVWKDWKDYHWKHLURULJLQLQWKH
'HFODUDWLRQRI+HOVLQNLDQGDUH FRQVLVWHQWZLWK,&+*RRG&OLQLF DO3UDFWLFHDSSOLFDEOH
UHJXODWRU\UHTXLUHPHQWVDQGWKH&DVWOH&UHHN3KDUPDFHXWLFDOÂ¶VS ROLF\RQ%LRHWKLFV
:ULWWHQ,QIRUPHG&RQVHQW$VVHQW
7KHLQYHVWLJDWRUDWHDFKLQYHVWLJDWLRQDOFHQWHUZLOOHQVXUHWKD WZULWWHQLQIRUPHGFRQVHQWIRUPV
WKDWSURYLGHLQIRUPDWLRQDERXWWKHVWXG\ZLOOEHJLYHQWRDGXOW VXEMHFWV)RUFKLOGDGROHVFHQW
VXEMHFWVZULWWHQLQIRUPHGFRQVHQWDQGDVVHQWIRUPVZLOOEHJLY HQWRWKHFDUHJLYHUDQGWRWKH
DSSOLFDEOHVXEMHFWUHVSHFWLYHO\,QIRUPHGFRQVHQWIRUPVZLOOF RQWDLQDOOWKHHOHPHQWVUHTXLUHGE\
WKH,&+(*XLGHOLQHIRU*&3DQGDQ\DGGLWLRQDOHOHPHQWVUHTXLU HGE\ORFDOUHJXODWLRQV7KH
LQIRUPDWLRQSURYLGHGLQWKHLQIRUPHGFRQVHQWZLOOEHLQDODQJX DJHXQGHUVWDQGDEOHWRWKHDGXOW
VXEMHFWVRUFDUHJLYHURIFKLOGDGROHVFHQWVXEMHFWV
7KHLQYHVWLJDWRUZLOOSURYLGHWKHVXEMHFWDQGRUFDUHJLYHUVXII LFLHQWWLPHWRFRQVLGHUZKHWKHUWR
SDUWLFLSDWHLQWKHWULDO7KHLQYHVWLJDWRUZLOOH[SODLQWRWKH VXEMHFWFDUHJLYHUWKDWWULDO
SDUWLFLSDWLRQLVYROXQWDU\DQGZLWKGUDZDOIURPWKHVWXG\LVDOO RZHGDWDQ\WLPHDQGZLWKGUDZDO
ZLOOQRWDGYHUVHO\DIIHFWWKHVXEMHFWÂ¶VPHGLFDOFDUH
$WWKHILUVWVWXG\YLVLWSULRUWRWKHLQLWLDWLRQRIDQ\VWXG\UHODWHGSURFHGXUHVVXEMHFWVFDUHJLYHUV
ZLOOEHDVNHGWRJLYHZULWWHQLQIRUPHGFRQVHQWDQGFKLOGDGROHVFHQWVXEMHFWVZLOOEHDVNHGWR
JLYHDVVHQWDIWHUKDYLQJEHHQLQI RUPHGRIWKHQDWXUHRIWKHVW XG\VWXG\SURFHGXUHVDQG
UHVWULFWLRQVDQGULVNVDQGEHQHI LWV7KHLQIRUPHGFRQVHQWDQGD VVHQWGRFXPHQWVDVDSSOLFDEOH
PXVWEHVLJQHGDQGGDWHGE\WKHVXEMHFWFDUHJLYHUSULRUWRVWXG \SDUWLFLSDWLRQ&RSLHVRIWKH
VLJQHGLQIRUPHGFRQVHQWDQGDVVH QWGRFXPHQWVPXVWEHJLYHQWRW KHVXEMHFWFDUHJLYHU
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

7KH86)'$GRHVQRWGHILQHWKHUHTXLUHGHOHPHQWVRIDQDVVHQW KRZHYHUWKH\PXVWEHDFFXUDWH
QRWEHFRHUFLYHDQGPXVWLQFRUSR UDWHDJHDSSURSULDWHZRUGLQJ3 DUHQWVJXDUGLDQVFDUHJLYHUV
PXVWEHJLYHQDQ,5%(&DSSURYHG,&)WRUHYLHZVLJQDQGGDWH/RFDO,5%(&UHTXLUHPHQWV
VXUURXQGLQJDVVHQWVKRXOGEHIROORZHG
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

'$7$+$1'/,1*$1'5(&25'.((3,1*
(OHFWURQLF&DVH5HSRUW)RUPV
$GHTXDWHDQGDFFXUDWHFDVHUHFRUGVZLOOEHPDLQWDLQHGDQGDOOUHOHYDQWREVHUYDWLRQVDQGGDWD
UHODWHGWRWKHVWXG\ZLOOEHUHFRUGHG
(OHFWURQLF&5)VDQGVXEMHFWGLDULHVZLOOEHXVHGLQWKLVVWXG\ 7KH&5)ZLOOEHHOHFWURQLFDOO\
VLJQHGDQGGDWHGE\WKH3ULQFLSDO,QYHVWLJDWRURUKLVGHVLJQHH DIWHUKLVKHUUHYLHZ$IWHUWKH
FRPSOHWLRQRIWKHVWXG\FRPSOHWHG&5)VZLOOEHUHWDLQHGLQWKH DUFKLYHV
&RPSOHWHG&5)VZLOOEHUHYLHZHGE\WKHVWXG\PRQLWRULQWKHHOH FWURQLFGDWDFDSWXUHV\VWHP
DJDLQVWWKHVRXUFHGRFXPHQWDWLRQIRUDFFXUDF\DQGFRPSOHWHQHVV 
,QVSHFWLRQRI5HFRUGV
&DVWOH&UHHN3KDUPDFHXWLFDOV //&ZLOOEHDOORZHGWRFRQGXFWVLWHYLVLWVWRWKHLQYHVWLJDWLRQ
IDFLOLWLHVIRUWKHSXUSRVHRIPRQLWRULQJDQ\DVSHFWRIWKHVWXG \7KH,QYHVWLJDWRUDJUHHVWRDOORZ
WKHPRQLWRUWRLQVSHFWWKHGUXJ VWRUDJHDUHDVWXG\GUXJVWRFNV GUXJDFFRXQWDELOLW\UHFRUGV
VXEMHFWFKDUWVDQGVWXG\VRXUFHGRFXPHQWVDQGRWKHUUHFRUGVUH ODWLYHWRVWXG\FRQGXFW
5HWHQWLRQRI5HFRUGV
7KH3ULQFLSDO,QYHVWLJDWRUPXVWPDLQWDLQDOOGRFXPHQWDWLRQUHOD WLQJWRWKHVWXG\IRUDSHULRGRI
\HDUVDIWHUWKHODVWPDUNHWLQJDSSOLFDWLRQDSSURYDORULIQRW DSSURYHG\HDUVIROORZLQJWKH
GLVFRQWLQXDQFHRIWKHWHVWDUWLF OHIRULQYHVWLJDWLRQ,ILWEHF RPHVQHFHVVDU\IRU&DVWOH&UHHN
3KDUPDFHXWLFDOV//&RUWKH5HJXODWRU\$XWKRULW\WRUHYLHZDQ\ GRFXPHQWDWLRQUHODWLQJWRWKH
VWXG\WKH,QYHVWLJDWRUPXVWSHUPLWDFFHVVWRVXFKUHFRUGV
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

38%/,&$7,2132/,&<
7KHLQYHVWLJDWRULVREOLJHGWR SURYLGHWKHVSRQVRUZLWKFRPSOHW HWHVWUHVXOWVDQGDOOGDWDGHULYHG
E\WKHLQYHVWLJDWRUIURPWKHVWXG\'XULQJWKHVWXG\RQO\WKH 6SRQVRUPD\PDNHVWXG\
LQIRUPDWLRQDYDLODEOHWRRWKHUVWXG\LQYHVWLJDWRUVRUWRUHJXOD WRU\DJHQFLHVH[FHSWDVUHTXLUHGE\
ODZRUUHJXODWLRQ([FHSWDVRWKHUZLVHDOORZDEOHLQWKHFOLQLFD OVWXG\VLWHDJUHHPHQWDQ\SXEOLF
GLVFORVXUHLQFOXGLQJSXEOLFO\DFFHVVLEOHZHEVLWHVUHODWHGWR WKHSURWRFRORUVWXG\UHVXOWVRWKHU
WKDQVWXG\UHFUXLWPHQWPDWHULDOVDQGRUDGYHUWLVHPHQWVLVWKH VROHUHVSRQVLELOLW\RIWKH6SRQVRU
7KH6SRQVRUPD\SXEOLVKDQ\GDWDDQGLQIRUPDWLRQIURPWKHVWXG\ LQFOXGLQJGDWDDQG
LQIRUPDWLRQJHQHUDWHGE\WKHL QYHVWLJDWRUZLWKRXWWKHFRQVHQW RIWKHLQYHVWLJDWRU0DQXVFULSW
DXWKRUVKLSIRUDQ\SHHUUHYLHZHGSXEOLFDWLRQZLOODSSURSULDWHO\ UHIOHFWFRQWULEXWLRQVWRWKH
SURGXFWLRQDQGUHYLHZRIWKHGRFXP HQW$OOSXEOLFDWLRQVDQGSUH VHQWDWLRQVPXVWEHSUHSDUHGLQ
DFFRUGDQFHZLWKWKLVVHFWLRQDQGWKH&OLQLFDO6WXG\6LWH$JUHHP HQW,QWKHHYHQWRIDQ\
GLVFUHSDQF\EHWZHHQWKHSURWRFRODQGWKH&OLQLFDO6WXG\6LWH$J UHHPHQWWKH&OLQLFDO6WXG\6LWH
$JUHHPHQWZLOOSUHYDLO
,IWKHVWXG\LVEHLQJFRQGXFWHGDVSDUWRIDPXOWLFHQWHUFOLQLF DOVWXG\GDWDIURPDOOVLWHV
SDUWLFLSDWLQJLQWKHVWXG\ZLOOEHSRROHGDQGDQDO\]HGE\WKH6 SRQVRURUWKH6SRQVRUÂ¶VGHVLJQHH
7KHILUVWSXEOLFDWLRQRIWKHVWXG\UHVXOWVVKDOOEHPDGHLQFRQMXQFWLRQZLWKWKHUHVXOWVIURPRWKHU
VWXG\VLWHVDVDPXOWLFHQWHUSXEOLFDWLRQ,IDPXOWLFHQWHUSXEO LFDWLRQLVQRWIRUWKFRPLQJZLWKLQ
PRQWKVRIFRPSOHWLRQRIWKHVWXG\ DWDOOVLWHVWKHLQYHVWLJDWR UPD\SXEOLVKRUSUHVHQWWKHUHVXOWV
JHQHUDWHGDWKLVRUKHUVLWH
7KHLQYHVWLJDWRUZLOOSURYLGHWKH6SRQVRUZLWKDFRS\RIDQ\SU RSRVHGSXEOLFDWLRQRU
SUHVHQWDWLRQIRUUHYLHZDQGFRPPH QWDWOHDVWGD\VSULRUWRV XFKSUHVHQWDWLRQRUVXEPLVVLRQ
IRUSXEOLFDWLRQ7KH6SRQVRUVKD OOLQIRUPWKHLQYHVWLJDWRULQZ ULWLQJRIDQ\FKDQJHVRUGHOHWLRQV
LQVXFKSUHVHQWDWLRQRUSXEOLFDWLRQUHTXLUHGWRSURWHFWWKH6SR QVRUÂ¶VFRQILGHQWLDODQGSURSULHWDU\
WHFKQLFDOLQIRUPDWLRQDQGWRDGGU HVVLQDFFXUDWHGDWDRULQDSSUR SULDWHLQWHUSUHWDWLRQVLQWKH
FRQWH[WRIDQ\SRROHGPXOWLFHQWHUUHVXOWV$WWKHH[SLUDWLRQRI VXFKGD\SHULRGWKH
LQYHVWLJDWRUPD\SURFHHGZLWKWKHSUHVHQWDWLRQRUVXEPLVVLRQIR USXEOLFDWLRQXQOHVVWKH6SRQVRU
KDVQRWLILHGWKHLQVWLWXWLRQRUWKHLQYHVWLJDWRULQZULWLQJWKD WVXFKSURSRVHGSXEOLFDWLRQRU
SUHVHQWDWLRQGLVFORVHVWKH6SRQVRUÂ¶VFRQILGHQWLDODQGSURSULHWD U\WHFKQLFDOLQIRUPDWLRQ)XUWKHU
XSRQWKHUHTXHVWRIWKH6SRQVRUWKHLQYHVWLJDWRUZLOOGHOD\WK HSXEOLFDWLRQRUSUHVHQWDWLRQIRUDQ
DGGLWLRQDOGD\VWRSHUPLWWKH 6SRQVRUWRWDNHQHFHVVDU\DFWL RQVWRSURWHFWLWVLQWHOOHFWXDO
SURSHUW\LQWHUHVWV
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020

&DVWOH&UHHN3KDUPDFHXWLFDOV//&
,QYHVWLJDWLRQDO3URGXFW'LDFHUHLQ2LQWPHQW3URWRFRO1R&&3
*OREDO3URWRFRO$PHQGPHQW
3DJHRI

5()(5(1&(6
6DODYDVWUX&0HWDO5HFRPPHQGH GVWUDWHJLHVIRUHSLGHUPRO\ VLVEXOORVDPDQDJHPHQW
LQ5RPDQLD0DHGLFD%XFKD US
+RQ./HWDO$JHDQGHWLRORJ \RIFKLOGKRRGH SLGHUPRO\VLV EXOORVDPRUWDOLW\
-'HUPDWRORJ7UHDWS
)LQH-'HWDO,QKHULWHGHSLG HUPRO\VLVEXOORVDXSGDWHGUH FRPPHQGDWLRQVRQ
GLDJQRVLVDQGFODVVLILFDWLRQ-$P$FDG'HUPDWROS
)LQH-(SLGHPLRORJ\RI,QKHUL WHG(SLGHUPRO\VLV%XOORVD%DVHG RQ,QFLGHQFH
DQG3UHYDOHQFH(VWLPDWHV)URPWK H1DWLRQDO(SLGHUPRO\VLV%XOORV D5HJLVWU\
-$0$'HUPDWRORJ\S
1LFRODV3&OLQLFDO3KDUPDFRNLQ HWLFVRI'LDFHUHLQ&OLQ3KDUP DFRNLQHW
1RYS
:DOO\9HWDO'LDFHUHLQIRUW KHWUHDWPHQWRIHSLGHUPRO\VLVEXOORVDÂ²DSKDVH,,
UDQGRPL]HGSODFHERFRQWUROOHGGRXEOHEOLQGPXOWLFHQWHUFOLQL FDOWULDO
3UHVHQWHGDWWKHWK(XURSHDQ$FDGHP\RI'HUPDWRORJ\DQG9HQHURORJ\
&RQJUHVV2FWREHU 9LHQQD$XVWULD
Castle Creek Pharmaceuticals, LLC 
Clinical Study Report CCP-020-302
Confidential & Proprietary 
Version 1.0, 08 July 2020
